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T owards the end of 2013 we can look back at a very active year in our society. This newsletter emphasises the activities in our standing com-
mittees. With your input (comments and contributions) we 
are looking forward to offer you even more value for being 
a member of SA Heart. It is sad however to see how many 
members have either not renewed their membership in 
2012 or just did not care to be a member and contribute 
to make the practising of cardiology in South Africa more 
successful. 
The latest newsletter from the World Congress of 
Paediatric Cardiology & Cardiac Surgery 2013 highlighted 
an extensive adult content as this congress incorporates 
the annual SA Heart Congress for 2013. I hope to see you 
all in Cape Town to gain from this prestigious event 
and support your colleagues during February next year. 
We have submitted our bid for the World Cardiology 
Congress 2016 Cape Town and should know before 
middle 2013 whether we will host yet another world event 
in South Africa. 
You are again invited to submit specific problems with 
funders to our private practice committee. They envisage a 
meeting with funders highlighting their inexplicable, some-
times thoughtless or counter-productive, decisions. The 
more clinical cases we can use as examples the greater the 
success this meeting will be. 
I recently had a patient with symptomatic ventricular 
fibrillation and bradycardia with nodal escape which 
fortunately up till now terminated spontaneously. With 
LVEF of 50% an RV ICD the minimum therapy was 
required. It took me many telephone calls and letters to 
the funder and, only after highlighting the potential claim 
should this patient die, did it authorise implantation of 
an ICD 6 weeks later. The funder in question then had 
the audacity to backdate its letter of authorisation to 
6 weeks earlier when we first requested authorisation. 
Some funders decided to pay the members as my bill was 
marginally higher than its rate of reimbursement and the 
patients subsequently spent the money. One can consider 
this as theft by the patient with the funder as accomplice. 
ACTIVE, PRODUCTIVE 2012 FOR SOCIETY
Such actions by funders will certainly not promote better 
cooperation between service providers and funders. 
An Ethics Forum consisting of members of the SA Heart 
Exco and industry representatives will discuss the ethical 
norms for sponsorship and support from industry to SA 
Heart and its members. Members are invited to forward 
their comments on the matter. 
As part of the “Young Cardiologists of Tomorrow” pro-
gramme the ESC offered free registration to a number of 
cardiologists in training who were recommended by the 
respective national society in this case, SA Heart. The 
incumbents must not have attended an European Society 
of Cardiology (ESC) congress before, nor have had an 
abstract accepted at the congress previously and be under 
the age of 36. 
The medical schools made recommendations and 5 
candidates were chosen to attend this year’s ESC congress. 
Some last minute substitutions due to unforeseen circum-
stances in certain units were made, and SASCI stepped in 
to secure funding for travel and accommodation for the 
registrars. Please read the reports on their experiences.
Adriaan Snyders 
Editor SA Heart newsletter & President SA Heart 
asnyders@mweb.co.za 
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15 000 hearts 1 SHAREd story
By mid-2012 SHARE achieved the huge milestone of capturing 15 000 Cathlab cases. 
During the past few years the cases captured have doubled annually, and for 2012 it is projected that 6 000 cases will be 
entered. Moreover, the surgical data base currently stands at an impressive 2 800 cases.
Data quality has improved, due to the introduction of an automated check of the mandatory dataset. The Cathlab cases are 
captured at 21 sites, 4 of which are in the public sector, by just over 70 individual doctors (15 to 20 in the public sector). 
Three quarters of the cases captured are in private hospitals, and not unexpectedly the case distribution is skewed towards 
Gauteng, which has 16 sites, followed by 2 each in the Western Cape and KwaZulu-Natal, and 1 in the Eastern Cape.
Karen Sliwa’s co-option to the SHARE working group has renewed the focus on SHARE as a research database, which should 
in due course improve clinical excellence in South African cardiology, by highlighting local clinical trends against the bench-
mark of other international registries. The SHARE focus at the moment is to publish in a reputable international journal in 
2013, and to host workshops at both the World Congress of Paediatric Cardiology in Cape Town, and the European Society 
of Cardiology (ESC) meeting.
The message to members is that SHARE is alive and well, and that with increasing pressure on the cardiology community from 
both government and private funders, the ability to self-review, and to respond to issues with our own data from the SHARE 
project, should not be undervalued.
Your continued support of this most important programme is greatly appreciated.
SHARE (SA HEART ASSOCIATION REGISTRY)
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POPULAR CONGRESSES FOR 2012 / 2013
 CONGRESS DATE CITY COUNTRY
ICI MEETING 2012 INNOVATIONS IN  2 - 4 December 2012 Tel Aviv Israel
CARDIOVASCULAR INTERVENTIONS 
http://www.icimeeting.com
EUROECHO 2012 5 - 8 December 2012 Athens Greece  
http://www.escardio.org/congresses/euroecho2012
WORLD CONGRESS OF CLINICAL LIPIDOLOGY 6 - 8 December 2012 Budapest Hungary
http://www.clinical-lipidology.com
NEW YORK CARDIOVASCULAR SYMPOSIUM 7 - 9 December 2012 New York USA 
http://www.Cardiosource.org/nycvsymposiumD2
6TH WORLD CONGRESS ON PAEDIATRIC  17 - 22 February 2013 Cape Town South Africa
CARDIOLOGY & CARDIAC SURGERY
http://www.pccs2013.co.za 
SA HEART 2013 17 - 22 February 2013 Cape Town South Africa
http://www.saheart.org
JIM 2013 14 - 16 February 2013 Rome  Italy 
http://www.jim-vascular.com
ACC 2013 09 - 13 March 2013 San Francisco USA 
http://www.scientificsessions.cardiosource.org
EUROHEARTCARE 22 - 23 March 2013 Glasgow UK 
http://www.escardio.org/congresses
EUROPREVENT 2013 18 - 20 April 2013 Rome Italy 
http://www.escardio.org/congresses
11TH PASCAR CONGRESS AND  15 - 20 May 2013 Dakar Senegal
4TH ALL AFRICA CONFERENCE ON 
HEART DISEASE, STROKE AND DIABETES 
http://www.pascar.co.za  
EUROPCR 2013 21 - 24 May 2013 Paris France 
http://www.europcr.com
ESH 2013 14 - 17 June 2013 Milan Italy 
http://www.eshonline.org
8TH INTERNATIONAL MEETING IN  16 - 18 June 2013 Jerusalem Israel
INTENSIVE CARDIAC CARE 
http://www.isas.co.il/cardiac-care2013
EHRA - EUROPACE 23 - 26 June 2013 Athens Greece
http://www.escardio.org/congresses/ehra-europace-2013 
ESC 2013 31 August - 4 September 2013 Amsterdam Netherlands 
http://www.escardio.org/congresses
VENICE ARRHYTHMIA 2013 6 - 9 October 2013 Venice Italy 
http://www.venicearrhythmia.org
Continued on page 292
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POPULAR CONGRESSES FOR 2012 / 2013 continued
 CONGRESS DATE CITY COUNTRY
ICC - INTERNATIONAL CONGRESS 8 - 13 October 2013 Chicago Il USA
OF CARDIOLOGY 
CHEST 26 - 31 October 2013 Chicago Il USA 
http://accmeeting.org/chest.2013
TCT 2013 29 October - 1 November 2013 San Francisco USA 
http://www.tctconference.com
AHA 2013 16 - 20 November 2013 Dallas, Texas USA 
http://www.scientifi ca sessions.org
5TH INTERNATIONAL CONFERENCE ON FIXED 21 - 24 November 2013 Bangkok Thailand
COMBINATIONS IN THE TREATMENT OF
HYPERTENSION, DYSLIPIDAEMIA AND 
DIABETES MELLITUS
http://www.fi xedcombinations.com
 
REPORT ON THE EDUCATION COMMITTEE  
New members were added to the education committee (EC) since the SA Heart Congress in July. Dr Brian Vezi was co-
opted after the untimely death of Prof AO Okreglicky; Prof Pro Obel will also participate; and Dr Andre Brooks will represent 
the Paediatric Cardiac Society.
The issue around CASSA accreditation for ICD operators was revised and the status would be changed from accreditation 
to endorsement. The final document is still pending
The committee will revise the standards for Certification in Cardiology with our national coordinator Prof Commerford. 
A representative of this committee as well as Dr Tom Mabin will form part of the new central congress organising committee 
(SAHCOC). The education committee will oversee any national education lecture series.
Dr Martin Mpe
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SA CARDIOLOGIST PLACES CAPE TOWN AT FOREFRONT OF 
INTERNATIONAL MEDICINE
300 life saving heart procedures and counting
A Cape Town based medical team has once again placed 
the city of Cape Town at the forefront of international 
medicine, having completed over 300 life saving heart 
procedures using a robotic catheter system. This is the 
highest number of procedures of this kind ever performed 
in the world. 
Dr Faizel Lorgat, an interventional cardiologist practicing at 
the Netcare Christiaan Barnard Memorial Hospital in Cape 
Town, specialises in the treatment of heart rhythm 
disturbances or arrhythmias. Dr Lorgat and his team have 
now completed 333 arrhythmia procedures using the 
state-of-the-art Sensei Robotic Catheter system, which 
was introduced at the hospital in September 2009.
“Dr Lorgat was the first medical specialist in the world to 
complete more than 300 of these extremely tricky pro-
cedures using this sophisticated technology,” notes Chris 
Tilney, General Manager of the Netcare Christiaan Barnard 
Memorial Hospital. “This is an outstanding achievement, 
which positions Dr Lorgat as the global leader in the 
treatment of arrhythmias.”
Dr Lorgat is the only cardiologist specialising in electro-
physiology at the Netcare Christiaan Barnard Memorial 
Hospital and one of only a handful in South Africa. The 
Cape Town facility was the first centre in the Southern 
Hemisphere to use the Sensei Robotic Catheter system 
and it remains one of only two centres (the other is 
in Australia) to utilise this cutting edge technology. 
Dr Lorgat’s vision of transforming Netcare Christiaan 
Barnard Memorial Hospital into an international referral 
centre for the treatment of arrhythmias has become a 
reality and today it treats patients from around South 
Africa and the sub-continent.
Dr Lorgat explains that the Sensei Robotic Catheter 
system allows “short circuits” in the heart to be destroyed 
with a heated catheter tip. This enables the heart’s rhythm 
to return to normal, reducing the need for other treatments 
such as pacemakers and drugs. He says the robotic system 
allows greater control over the catheter compared to the 
manual techniques that have traditionally been used. 
The electrophysiology unit at the Netcare Christiaan 
Barnard Memorial Hospital is becoming known for its firsts. 
The Sensei Robotic Catheter system has never been used 
before to treat arrhythmias in the ventricular tachycardia 
of the heart. Dr Lorgat is the first cardiologist ever to 
perform this procedure with this technology, and has 
already successfully treated six patients. 
Dr Logat says that ventricular tachycardia (VT) arises from 
the bottom chambers of the heart and until now it has 
been difficult to correct electrical dysfunction found there. 
Arrhythmias originating in the ventricles are generally life 
threatening and need to be treated. 
Dr Lorgat – one of modern medicine’s true innovators - 
recently performed the procedure on a male patient who 
was suffering from a serious arrhythmia originating from his 
ventricles and was starting to suffer kidney failure as a 
result of a lack of oxygen. Doctors had given the patient a 
poor prognosis, but following the highly successful pro-
cedure performed by Dr Lorgat, the patient’s arrhythmia 
was completely healed.
Dr Lorgat has also been the first cardiologist in the world 
to use the integrated Lynx catheter and sheath with the 
Sensei system. The Lynx has less set-up time than other 
technologies and is smaller in diameter. Dr Lorgat has 
shared his experience with the Lynx with the international 
medical fraternity through co-authored medical papers.
Dr Lorgat is of the opinion that the Sensei Robotic 
Catheter system has “already withstood the test of time 
and proved itself a major advance in the treatment of heart 
rhythm disturbances”. He says the efficiency of the system 
should see it becoming standard equipment for the 
treatment of electrical problems in the heart. While other 
remote systems have been introduced to South Africa they 
have so far not proved as user friendly or effective.
The Sensei system at the Netcare Christiaan Barnard 
Memorial Hospital was purchased from developers Hansen 
Medical through local distributor Amayeza Abuntu 
Biomedical.
With acknowledgement: Cape Argus, Wed. 1 Feb. 2012.
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HEART FAILURE SOCIETY OF SOUTH AFRICA NEWS
Ongoing education, research gain impetus
Herewith the report on HeFSSA’s activities over the last 
few months and our plans for 2013:
I congratulate the new members of the Exco and those 
who have assumed different responsibilities. Prof Karen 
Sliwa, immediate past president, will continue her significant 
contributions to the Society as an Exco member. My own 
and the Society’s appreciation goes to Karen who was the 
main driving force in our establishment. Her dedication 
over the past 6 years has been immense and is much 
appreciated.
The following members continue on Exco (office in 
brackets): Eric Klug (president), Martin Mpe (vice-
president), Darryl Smith (treasurer), Jens Hitzeroth 
(secretary), T. Lachman, P. Obel, C. Radulescu, J. Vorster 
and S. Lecour. Luigi Zampieri represents industry.
GP Cardio Update 2012
To achieve our educational goals, HeFSSA once again 
organised the Cardio Update for Non-Cardiologists at 
2012’s Sun City SA Heart Congress. As this programme 
is proudly sponsored by AstraZeneca, we were able to 
offer it at no charge to local medical practitioners. A total 
of 140 GPs registered and all the sessions were well 
attended. Dr Martin Mpe was the convener  with other 
Exco members, including Prof Karen Sliwa, Drs Eric Klug 
and Jean Vorster who was part of the academic faculty. 
I thank them for their time and commitment to this 
successful programme.
The HeFSSA and HeFSSA/SASCAR parallel sessions at SA 
Heart 2012 Congress were well attended and feedback 
from the attendees shows that the topics, such as Acute 
Heart Failure were highly informative and educational.
HeFSSA - Acute heart failure: Detection and management, Ballroom north @ 11h00 - 13h00
11h00 - 13h00  Parallel Session 1: HeFFSA - Acute heart failure:  Chairperson: Dr M. Mpe (SA)
  Detection and management   
11h00 - 11h30 Detection and management of acute viral myocarditis Prof L. Cooper (USA) 
11h30 - 12h00 Detection and management of acute heart failure in pregnancy Prof K. Sliwa (SA)
12h00 - 12h30 Detection and management of acute heart failure in the elderly Dr E. Klug (SA)
12h30 - 13h00 What is new in the management of acute heart failure Dr T. Lachman (SA) 
  (based on ESC guidelines)
SASCAR/HeFSSA Workshop - Acute heart failure: From bench to bedside
Ballroom north @ 14h00 - 16h30 
14h00 - 16h30  Parallel Session 2: SASCAR/HeFSSA Workshop Chairpersons: Proff K. Sliwa
  Acute heart failure: From bench to bedside    and S. Lecour (SA)
14h00 - 14h30  Histology and biomarkers in viral myocarditis Prof L. Cooper (USA) 
14h30 - 15h00  Biomarkers in heart failure: BNP and beyond Prof H. Katus (Germany) 
15h00 - 15h30  Micro particles as a new biomarker for heart failure Dr K. Bachelier (Germany) 
15h30 - 16h00  Metabolic changes in acute heart failure Prof L. Opie (SA)
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SASCAR/HeFSSA Workshop - Acute heart failure: From bench to bedside continued
   Abstract presentations
16h00 - 16h15  Clinical and Echocardiographic follow-up of the Isolated Left  Dr F. Botha (SA)
  Ventricular Non Compaction cohort at Chris Hani Baragwanath Hospital  
16h15 - 16h30  Potential mechanisms that account for obesity-related  Dr C.D. Libhaber (SA)
  decreases in left ventricular diastolic function   
Continued on page 296
GP HF programmes 2012    
Following the success of the GP Heart Failure programmes 
(2010 - 2011) the HeFSSA Exco decided to continue the 
educational programme. The rural areas need to be 
targeted and GPs have expressed the need for further 
cardiac education. The current programme’s goal  is to 
expand on the basic pathophysiology and management of 
Heart Failure (HF) with a particular focus on Acute Heart 
Failure and Right Ventricle Heart Failure. There are 14 GP 
meetings planned for this year (4 August - 3 November) 
which will be held in Nelspruit, Cape Town, Durban, 
Pretoria, Port Elizabeth, Johannesburg, George, Rustenburg, 
East-Rand, Bloemfontein, Potchefstroom, Windhoek and 
Walvis Bay. The slide compendium was prepared by 
Eric Klug, Karen Sliwa, Martin Mpe, Pro Obel and 
Tony Lachman. These programmes are sponsored by 
AstraZeneca, Pharma Dynamics and Servier as primary 
sponsors with Medtronic as a secondary contributor.
We are planning the HF programme for 2013 which will 
follow a clinical, case-based approach.  
HeFSSA HF travel scholarship
HeFSSA considers the support of this award to be part of 
its contribution towards optimising patient health care 
and to enhance and further local expertise in Heart Failure 
in South Africa. For more information on this R 50 000 
annual travel scholarship, visit Education on our website 
www.hefssa.org. You can also contact our office at 
083 458 5954.
HeFSSA is also involved in research programmes as 
research forms part of our Society’s mission. We are 
currently involved in the Inter-CHF study (A McMaster 
University/PHRI registry initiative led by Prof Karen Sliwa) 
as well as the Global Awareness and Perception Study in 
HF (GAPS, a World Heart Failure Society Initiative managed 
by Dr Jens Hitzeroth).  
There are wide variations in the management of HF both 
within and also between countries. The GAPS questionnaire 
aims to describe the diagnosis and the different forms of 
care and treatment of HF across a wide variety of countries 
by medical practitioners managing HF patients. Please 
contact the HeFSSA office if you need more information or 
go to http://gaps-hf.whfs.org to be part of this important 
survey.  
The impact of this inter-country HF registry is of great 
significance:
 ■   It will be the largest systematic evaluation of HF in 
lower and middle income countries in Africa, Asia and 
South America;
 ■   The registry will describe the causes, clinical risk factors 
and burden of disease; document the prevalent 
approaches to patient management; and identify gaps in 
the care of HF patients;
 ■   It  will also examine patient and physician knowledge 
and perceptions towards HF, and identify barriers to 
prevention and treatment, thereby suggesting possible 
solutions, which may then be evaluated in future 
studies.
SAHJ spring 2012 newsletter.indd   295 2012/11/29   8:14 PM
296
sa heart
 
Such information will also be critical for the development 
of National guidelines, research programmes, and possible 
policies and interventions. If you are interested, please 
contact the HeFSSA office. The aim is to capture the 
information of at least 400 South African heart failure 
patients. 
Discovery Health HF Programme 
This is a home-based nurse-led programme which HeFSSA 
as a society under the leadership of Eric Klug structured 
and conceptualised. We trust it will hopefully be relevant 
to all patients with heart failure and not just for specific 
medical funders.   
HF Guideline and Algorithm 
The committee has updated the Chronic Heart Failure 
Algorithm of 2008. Our Exco discussed the changes 
extensively and a new, updated algorithm was designed 
(based on ESC 2011 CHF guidelines) and accepted by the 
Exco. The updated algorithm will be used as part of the GP 
education programme. We are also looking at the possi-
bility of a HeFSSA pamphlet series and a Guideline 2012 
Update highlighting the new changes and different areas of 
emphasis with regards to South Africa.
Website 
www.hefssa.org  
HeFSSA’s website is well maintained and updated to 
ensure that a visitor gets the latest news, publications and 
general information on upcoming events. Our Exco 
contributes to ensure that content stays relevant and 
interesting. The website is also updated with current 
lecture material and information on our 2012 GP 
Programme. 
We are also looking into the development of a web-based 
invitation and registration programme with the ability to 
earn CPD points thus ensuring that we maintain our 
professional status and to assist us in our quest to drive 
more people to the website as well. 
An informative hard copy leaflet/pamphlet or HeFSSA 
“business card” with the aim of driving medical practitioners 
to our website is also planned for 2013. The minutes of 
the AGM as well as the Annual Report for 2012 are also 
available here.
HeFSSA NEWS continued
HeFSSA can only achieve these goals thanks to our loyal 
corporate members who support us with generous 
educational grants. Our sincerest appreciation goes to 
AstraZeneca, Servier, Pharma Dynamics, Medtronic and 
Merck.
Please contact the HeFSSA office if you want to learn 
more about any of these events or want to participate in 
any of the programmes.
Contact details
George Nel Email: info@hefssa.org
  Cell: 083 458 5954
Sanette Zietsman Email: szietsman@telkomsa.net
  Cell: 083 253 5212
Dr Eric Klug
President of HeFSSA
HeFSSA’s 
website is well 
maintained and 
updated to ensure 
that a visitor gets 
the latest news, 
publications and 
general 
information on 
upcoming events.
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T he committee has grown to 8 in number with the recent welcome additions of Professor Karen Sliwa representing HeFSSA and Dr Ebrahim Hoosen 
representing the Paediatric Group.  (The original members 
remain Drs Cobus Badenhorst, James Fulton, Ronnie 
Jardine, Mpiko Ntsekhe, Les Osrin and Leslie Ponnusamy).
As regards the functionality of the committee, a set of 
principles has gradually evolved over the last year through 
discussions and trial and error, and include:
 ■   Matters other than the ESC guidelines are to be 
referred to the SA Heart Exco. 
 ■   Funding for the operations of the Ethics and Guidelines 
Committee including travel, accommodation, meetings 
and honoraria must come from SA Heart and not 
directly from industry. 
 ■   Declarations of (lack of) conflict of interest are to be 
obtained from participants in the review/consensus 
process before commencement. 
 ■   Each of these reviews/consensus statements will be 
headed by Task Force chairman (one of the committee 
members). 
 ■   A disclaimer against medico-legal consequences of 
guidelines/consensus statements should be included 
therein. 
 ■   Consensus/position statements on matters referred 
from SA Heart Exco will be published in the SA Heart 
Journal, SA Heart website and other journals as the 
need arises. 
 ■   Although ESC Guidelines are automatically adopted by 
the Association, new guidelines will be reviewed and 
annotations published in the SA Heart Journal.
The consensus statement for renal denervation which was 
drafted by members of the advisory board to Medtronic, 
has been modified (Dr Mpiko Ntsekhe) and will appear as 
a joint publication between the authors, SA Heart and SA 
Hypertension Society. The modifications relate mainly to 
the recommendation that patients who received this 
therapy must be enrolled in a prospective registry because 
a) there are no long term outcome data, and b) the unique 
South African demographic profile of the patients may 
produce different results. The other modification that we 
have recommended is that the decision for this therapy 
needs to be taken by or in consultation with a specialist 
(physician, cardiologist, nephrologist or endocrinologist) 
not performing the procedure. 
In regard to the last point, 6 new guidelines have been 
published by the ESC this year. It is our intention to serially 
review these and publish annotations one at a time in our 
newsletter. The first of these on cardiovascular disease 
prevention will appear in the next issue, authored by 
Dr Cobus Badenhorst. 
The new Heart Failure Guidelines have been reviewed by 
HeFSSA, and the committee has not participated in that 
process formally. It is of course necessary for the guide-
lines review process to include leaders from the relevant 
Special Interest Groups (SIGs), and it is envisaged that 
these reviews should include member(s) from both the 
E&G committee and the relevant SIGs in future. The other 
4 ESC guidelines under review are: atrial fibrillation 
(Drs R. Jardine), universal definition of MI (Dr L. Ponnusamy), 
ST-elevation MI (Dr L. Osrin), and valvular heart disease 
(Dr J. Fulton and L. Ponnusamy). 
Dr R.M. Jardine
Chairman: Ethics & Guidelines Committee
ETHICS AND GUIDELINES COMMITTEE FEEDBACK
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SOUTH AFRICAN SOCIETY FOR CARDIOVASCULAR RESEARCH (SASCAR)
I t is almost the end of the year and SASCAR’s activities over the past 3 months have been rich in events, with the SA Heart meeting and the 2nd UK/SA Cardiovascular 
Research workshop.
SA Heart meeting
For the 4th year in a row, a Basic Science programme was 
presented at the annual SA Heart congress in Sun City. 
SASCAR was involved in one independent session and a 
joint workshop with HeFSSA.  
Professor Lionel Opie opened the SASCAR session with a 
plenary lecture on “Metabolic therapy for acute myocardial 
infarction”. This was followed by plenary lectures by Prof 
Anna Mart Engelbrecht (University of Stellenbosch [US]), 
Prof Amanda Lochner (US) and Mr Gerald Maarmann 
(University of Cape Town [UCT]). 
Competition for the best abstract presentation was close 
and in the end Dr Sarah Pedretti (UCT) won the prize for 
best oral presentation in the Basic Research Category for 
her work on HDL/Sphingosine-1-phosphate induced car-
dioprotection and Ms. Lisa Uys (North West University) 
won the prize for best clinical research presentation for 
her work on the “Sympathetic activity and Ambulatory 
Blood Pressure in Africans” study.
The theme of this year’s joint SASCAR/HeFSSA workshop 
was “Acute Heart Failure; from bench to bedside”. The 
keynote lectures were presented by Prof L. Cooper (USA), 
Prof H. Katus (Germany), Dr K. Bachelier (Germany) and 
Prof Lionel Opie (University of Cape Town). 
Prof Amanda Lochner received the Cardiovascular Journal 
of Africa Award for Outstanding Research (in appreciation 
of her many contributions to cardiovascular medicine). 
Prof Lochner received her pre- as well as postgraduate 
training at the University of Stellenbosch. Afterwards she 
spent some time as a research fellow at the University of 
Texas, where she investigated the phenomenon of ethanol-
induced hypoglycaemia. After obtaining a DSc degree, she 
joined the CSIR Degenerative Diseases Group in the Dept 
of Internal Medicine at the US. Currently she is a member 
of the Heart Research group in the Dept of Biomedical 
Sciences of the Medical Research Council (MRC) Cape 
Heart Group.
Her research so far has focused on ischaemic heart disease 
with the aim of obtaining more insight into the molecular 
and cellular events during ischaemia and reperfusion injury 
of the heart as well as to develop strategies to prevent or 
attenuate these changes. Prof Lochner has 190 publications 
in peer-reviewed journals and she is actively involved in 
the training of postgraduate students. On behalf of all our 
members, we would like to express our sincerest congra-
tulations to Prof Lochner on her fantastic achievements.
Executive committee
Prof Sandrine Lecour (chair), Dr Neil Davies (treasurer), 
Prof Hans Strijdom (workshops), Miss Sylvia Dennis 
(secretary), Mr Gideon Burger (website) and Prof Karen 
Sliwa will remain on the committee for the next 2 years. 
Dr Roisin Kelly-Laubscher (newsletter and public relations) 
and Prof Anna-Mart Engelbrecht (workshops) have been 
elected as new Exco members.
Prof Amanda Lochner received the 
Cardiovascular Journal of Africa Award 
for Outstanding Research.
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2nd UK-SA Cardiovascular Workshop
The 2nd UK-SA Cardiovascular Research workshop was 
held in Cape Town in August 2012. The workshop hosted 
by SASCAR at UCT was organised by Prof Sandrine 
Lecour, head of the cardioprotection group at the Hatter 
Institute for Cardiovascular Research in Africa, UCT and 
Dr Derek Hausenloy, British Heart Foundation Senior 
Clinical Research Fellow at the Hatter Institute, University 
College, London. 
The main purpose of this Joint UK-SA Cardiovascular 
Research Workshop is to highlight the work of our young 
clinical and basic science researchers and to promote 
fruitful cardiovascular research collaborations between the 
UK and South Africa through the auspices of the European 
Society of Cardiology (ESC), UCT and SASCAR. 
The main research themes of the workshop represented 
the major overlapping research interests in both countries, 
and included novel cardioprotective therapeutic ap-
proaches, cardiomyopathies, cardiovascular risk factors, 
clinical cardiovascular research, signalling pathways in 
cardioprotection and myocardial ischaemia-reperfusion 
injury. There were also presentations on problems more 
relevant locally such as rheumatic heart disease: myocarditis 
in HIV associated cardiomyopathies; and the effects of 
antiretroviral therapy on cardiac contractile function. 
Over 65 delegates attended the workshop including invited 
faculty from Europe, the US and SA, 5 invited and spon-
sored Cardiovascular Research PhD students from aca-
demic institutions in Europe and approximately 50 South 
African cardiovascular researchers and students. At the 
beginning of the week, the 5 invited European students had 
the opportunity to visit and spend time in research 
laboratories in South Africa. The workshop took place on 
the Thursday and Friday and each of the European and 
South African students had the opportunity to present 
their work. 
Although the main aim of the workshop is to foster 
international collaboration, PhD students are also exposed 
to local opportunities, mainly through networking with 
local scientists at the workshop dinner. They also had the 
opportunity to listen to plenary talks by some of the most 
successful upcoming local researchers from the UCT (Prof 
Edward Sturrock, Dr Gasnat Shaboodien, Dr Liezl Zuhlke 
and Prof Sandrine Lecour), the US (Prof Faadiel Essop and 
Prof Hans Strijdom) and the University of Kwazulu Natal 
(Prof Sajidah Khan).
Based on their presentations, there was a prize for both 
the Best South African and Best European PhD student. 
Locally Ms Kathleen Reyskens from the US won with her 
work on the effects of antiretroviral treatment on the 
heart, while European student Ms Uma Mukherjee from 
the Hatter Institute at University College London got 
awarded  for her work on a molecule called DJ-1.
The student presentations were accompanied by plenary 
lectures from experts in cardiovascular research. A 
European Society for Cardiology extra nucleus meeting of 
the working group in cellular biology of the heart entitled 
“Frontiers in Cardioprotection” formed part of the pro-
gramme. Finally, the meeting was concluded with a 
presentation by Prof Lionel Opie on “How to become a 
successful researcher”.
One of the highlights of the 2nd joint meeting was that 
it extended past the UK borders with the participation 
of other European PhD students and cardiovascular 
researchers. The next UK-SA (or UK-EU) workshop will be 
held in France in 2 years’ time.
The event was funded by UCT and the European Society 
for Cardiology, a European exchange programme (PROMISE) 
and industry partners (SANOFI, Abcam).
Remember to visit our website www.sascar.org.za for 
more details on future workshops, our members and the 
latest information on the Society’s activities.
Dr Roisin Kelly
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PROGRESS WITH THE STEMI EARLY REPERFUSION PROJECT 
IN SOUTH AFRICA
T he optimal treatment for a STEMI patient is primary PCI (percutaneous cardiac intervention) within 90 minutes of first medical contact or within 120 
minutes from onset of symptoms. This is a proven and well 
researched fact and needs no further debate. In reality it is 
not always possible for a STEMI patient to get to a cathlab 
within 2 hours. Sometimes this is due to simple logistical 
issues e.g. the cathlab hospital is more than 2 hours away, 
or it would have been possible had the patient had a 
pathway to a cathlab managed by informed people and it 
was free of delays and bottlenecks.
Delays can severely compromise the patient’s quality of life 
and longevity and add cost by lengthening the patient’s stay 
in hospital, increasing downstream medical costs and 
causing the potential loss of productivity of economically 
active people.
The case for focussing on streamlining patient access to 
primary PCI is compelling. Based on a small-scale survey 
undertaken in the Pretoria area, it seems that South Africa 
falls far behind the ideal. The SA Heart Association 
therefore undertook to implement a project aimed at 
improving the situation. 
Project objectives
 ■   Improve quality of acute myocardial infarction (AMI) 
care;
 ■   Improve the network of care in order to give more 
patients access to reperfusion therapy; and
 ■  Decrease AMI mortality.
Project design
The approach used in South Africa is based on that of the 
Stent for Life programme in Europe which follows the 
following process:
 ■  Select a limited geographical area for a pilot study. 
 ■   Undertake a survey to measure the timeline of STEMI 
patients’ pathway to the cathlab as a baseline.
 ■   Develop a strategy for the removal of barriers in the 
pathway, including education and training of key players. 
 ■   Training commences in the cathlab/ICU, then emergency 
rooms at the cathlab hospitals followed by emergency 
services and the referral network of doctors and 
referring hospitals. The final leg is patient education 
and awareness.
 ■   Repeat the survey to measure results, which hopefully 
show an improvement in patient access to primary 
percutaneous cardiac intervention (PCI).
 ■   Roll-out the strategy in other areas.
The focus of attention is on STEMI patients only but, 
clearly, if we are able to improve the pathway for STEMIs, 
AMIs will benefit as well.
Current progress 
Pilot study
The Pretoria area was selected for the pilot study as it is 
manageable in terms of area and allows us to measure the 
pathway of patients living in Pretoria and in outlying areas 
without  cathlabs e.g. Witbank, Nelspruit and Polokwane. 
In other words, we get to measure a variety of cases.
Survey
There are 8 hospitals in Pretoria with cathlabs: 2 are public 
and 6 private. Due to a variety of factors, implementation 
of the survey took longer than expected but we have 
managed to implement it in 5 private hospitals. The survey 
phase will be completed by end September 2012 when we 
will have data on approximately 35 patients. The findings 
will be shared with all key stakeholders.
In addition to gathering data, the survey phase has been 
useful in terms of interacting and building relationships 
with stakeholders at each of the hospitals including the ER 
and ICU staff,  hospital management, cardiologists and in 
some cases head office clinical or quality control staff.     
Future plans
Educating & training medical staff
Crossroads of Abbot Vascular have 4 training modules 
available, each designed for specific groups:
 ■  Cathlab team and department
 ■  Emergency room staff
 ■  Clinical cardiologists and primary care physicians
 ■  Emergency medical services
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The course material requires some adjustments for the 
South African environment and we intend to undertake 
this exercise in the coming month.  
In the interim, training will be undertaken at the cathlab 
hospitals in Pretoria (hopefully all 8) and with the major 
EMS (emergency medical services) providers. We have 
identified/nominated the “lead cardiologist” in each 
hospital who will undertake the training – sessions of 
approximate 2 hours – at his/her hospital premises with 
the existing training kits as basis this year still.
Once the training material has been modified we will roll 
out the programme to all stakeholders in the referral 
network. We shall cover all of Pretoria and the cities and 
towns to the North. Special focus will be placed on the 
larger centres such as Witbank, Polokwane, etc. The 
programme will be planned this year for implementation 
early in 2013 and will be undertaken by Pretoria-based 
cardiologists.   
Patient awareness
We expect the training of all medical staff in Pretoria and 
the bulk of surrounding areas to be completed by April 
2013. Thereafter we shall commence a patient education 
and awareness programme. Depending on budget we will 
use regional and/or national media with print editorial, 
radio and TV interviews and other means of promotion. 
STEMI protocol
SA Heart is to undertake the development of the Protocol 
for STEMIs which will be based on the ESC Guidelines. 
Ultimately the protocol will require approval from the 
Guidelines Committee which could take some time.
We will develop printed material in simple language  to 
help emergency services paramedics, ER nurses and 
doctors with a protocol that enables optimal patient care: 
whether to “drip and ship” or “ship” immediately.    
In addition all paramedics and response teams from EMS 
providers will be given the telephone numbers and 
locations of the cathlab hospitals in print. In this way STEMI 
patients will be taken directly to a cathlab hospital and lives 
saved. The cellphone numbers of relevant cardiologists 
(with their permission) may also be included so that ECGs 
can be sent for diagnosis and preparation prior to the 
patients’ arrival.
Public sector
The involvement of the 2 public hospitals in Pretoria has 
been disappointing - a concern - as the bulk of STEMI 
patients receive treatment in this sector. We remain 
convinced that the case for early reperfusion is compelling. 
A presentation document is being drafted to highlight the 
benefits (including savings on downstream medical costs) 
of this project and representations will be made to 
appropriate people in government.
Funders
Similarly funders can benefit from patients receiving early 
reperfusion in a streamlined manner. A presentation docu-
ment will also be developed and presented to the major 
medical funders before year end.
Cecilia Andrews, Project manager
Adriaan Snyders, Project chairman
SA Heart is to 
undertake the 
development of the 
Protocol for STEMIs 
which will be 
based on the 
ESC Guidelines. 
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HEFSSA TRAVEL AWARD 
“ENHANCE HEART FAILURE MANAGEMENT IN SOUTH AFRICA”
Introduction
The Executive Committee of HeFSSA has established the 
Enhance Heart Failure Management Award. HeFSSA con-
siders this initiative as part of our contribution towards 
optimising patient health care and promoting local heart 
failure expertise. We hope that the information gained 
during this event and the possibility to share your 
experience and open a dialogue with other specialists will 
broaden all our knowledge with regard to new therapies in 
heart failure. We also hope that this experience will help 
you to develop educational programmes at your medical 
institution and/or to share the acquired knowledge with 
your patients and colleagues.
Value
The grant is valued at R50 000 (fifty thousand Rand) per 
annum and must be be utilised towards airfare (economy 
class), congress registration and accommodation expenses. 
The successful recipient is liable for all payments towards 
general expenses and airfares him/herself in advance, and 
can then claim these back from HeFSSA after submitting 
the necessary proof of payment and appropriate receipts. 
A recipient will be refunded immediately on receipt of 
these expenses.
Eligibility
Cardiologists or Physicians in either the Public or Private 
sector can be potential candidates and they are required 
to be a citizen or permanent resident of South Africa. The 
applicant’s annual SA Heart Association and HeFSSA’s 
membership fees must be fully paid up. The Congress/
Programme/Course must be internationally or locally 
accredited, and be predominantly focussed on Congestive 
Heart Failure.
Application procedure
Application forms are available on www.hefssa.org and 
must be completed and returned to HeFSSA, fax number: 
086 603 9885. 
Please take note of the following:
 ■   The application form must be accompanied by the 
official programme. Applications should be sent by email 
(as an attachment) in a single pdf file;
 ■   The title of the email should read: “HeFSSA Award 
towards Enhance Heart Failure Management in South 
Africa”; and
 ■   HeFSSA will acknowledge receipt of all applications by 
return email. 
Terms and conditions
It is hereby placed on record that no guarantees can be 
given to any applicant that his/her application will be 
successful.
The decision in granting an award to a successful applicant 
will be final. No appeal process will be considered.
Applicants will be notified of the outcome within 4 weeks 
of application.
The successful recipient of the grant needs to take note of 
the following:
 ■   An attendance certificate must be provided to HeFSSA 
on the applicant’s return;
 ■   You are bound to provide HeFSSA with a written 
evaluation/review of the course/conference no later 
than 3 months after returning;
 ■   Depending on the type of course/conference that the 
successful candidate attends, HeFSSA reserves its right 
to request the candidate to prepare and deliver a 
presentation at an appropriate forum; and
 ■   The successful recipient is liable for all payments towards 
general expenses and airfares him/herself in advance, 
and can then claim these back from HeFSSA after 
submitting the necessary proof of payment and appro-
priate receipts. A recipient will be refunded immediately 
on receipt of these expenses.
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ESC CONGRESS INSPIRES FURTHER STUDY
IAS visiting fellowship opportunities!
Application deadline
30 January 2013
It is with the greatest gratitude that I relate the experience 
regarding my nomination for, participation in and outcome 
of the ESC Congress 2012. I would first and foremost like 
to thank the ESC, SA Heart and SASCI for the opportunity 
afforded to cardiologists-in-training to attend such a 
prestigious event. ESC’s programme for the Cardiologists 
of Tomorrow is already benefitting more than 4000 young 
cardiologists or cardiologists-in-training from the 54 ESC 
member countries and 34 Affiliated cardiac societies – of 
which SA Heart is one. 
Further, I would like to thank my Head of Department 
(Cardiology - Steve Biko Academic Hospital/University of 
Pretoria) Prof Sarkin, for nominating me as a candidate for 
the scholarship. Lastly, but by no means least, I would like 
to express my appreciation to Pharma Dynamics, who 
sponsored my travel and accommodation costs during the 
congress. At this point as well, mention is in order of 
Medtronic, who, under the stewardship of Mr Claude van 
der Merwe, took us under their wing and looked after our 
entertainment needs. We enjoyed every bit of it.
The congress itself was a huge event, having been told that 
it had attracted more than 25000 delegates. The 
programme was elaborate, covering topics in heart failure, 
•  Improve your skills and knowledge in the field of cardiovascular disease.
•  Learn new research techniques.
•   Implement new techniques or initiate new programmes in atherosclerosis 
and cardiovascular disease.
Any researcher who is:
•  actively engaged in research in the field of cardiovascular disease; 
•  has an MD/PhD or an equivalent degree required; and 
•  40-years-old or less may apply.
Visiting Fellowship Award
3-month Visiting Fellowship award: $5 000
6-month Visiting Fellowship award: $8 000
Contact: Ann S. Jackson, Executive Director, Fellowships, Finances and Legal Affairs, International Atherosclerosis Society
Houston, TX, USA  l  Tel: +1 713 7979620  l  Email: ias@bcm.edu  l  Website: www.athero.org
coronary artery disease, arrhythmias, percutaneous 
interventions and valvular heart disease amongst others. At 
times, it was challenging to choose which talk to attend as 
all were very attractive, with world renowned speakers 
covering each of them. The landmark trials and subsequent 
change in the ESC Guidelines were one of the most 
appealing events to me.
What fascinated me most, were the highlights of the 
management-changing landmark trials such as WOEST 
(dropping of aspirin in patients who are on warfarin, aspirin 
and clopidogrel), PARAMOUNT (phase III trial of LCZ686 
in the management of diastolic heart failure) and a lot 
more that can be accessed on the ESC webcast.
This lifetime career experience has fascinated me to such 
an extent that I am more resolved than ever to embark on 
an academic and research career in cardiology by starting 
my PhD project in cardiomyopathy and to contribute to 
the body of knowledge in medicine and cardiology in 
particular.
Dr S.D. Mthiyane
Cardiology Fellow, Department of Cardiology
Steve Biko Academic Hospital/University of Pretoria
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SOUTH AFRICAN SOCIETY OF CARDIOVASCULAR INTERVENTION NEWS
I am pleased to report on our AGM and activities for the 
rest of 2012 and planning for 2013. 
Firstly, a big thank to my Exco for their continued willing-
ness to contribute and I am pleased to report that we have 
no vacancies to fill. I would like to restate my expressed 
gratitude to Graham Cassel for his immense contribution 
to SASCI as President during the past 4 years. Our cor-
porate member companies elected new representatives 
and it is a pleasure to welcome Craig Goodburn, Hans Buyl 
and Tracey du Preez. A big thank you goes to outgoing 
industry representatives Rob Millar, Salome Snyders and 
Mariska Fouché.       
Please note that you can contact our Exco members 
on issues relating to their portfolios or talk to George Nel 
at 083 458 5954 or sasci@sasci.co.za (SASCI Executive 
Officer). 
Farrel Hellig   President: AfricaPCR, Funders, 
International Relations and 
Congresses 
Sajidah Khan   Vice-President: AfricaPCR, 
international congresses, education 
and guidelines
Cobus Badenhorst   Treasurer: SHARE, SA Heart 
Congress 2012 and HS-troponin 
guidelines
Adie Horak   Secretary: SASCI @ WPCSSA  
Congress 2013 
Graham Cassel   Ex-officio President: AfricaPCR and 
non-invasive coronary imaging  
Mpiko Ntsekhe   Academic: visiting professors 
programme and HS-troponin 
guidelines 
Chris Zambakides   Johannesburg and academic: TAVI 
funding and CTO working group  
Len Steingo  SA Heart PPC: coding and funders 
Mark Abelson  SA Heart PPC: coding and funders 
Dave Kettles   Eastern Cape: fellows workshop 2012 
Jean Vorster  Pretoria: funders 
Gill Longano  ISCAP 
Liezel La Grange   ISCAP
2012 has been an exceptionally busy period. We are in the 
midst of flux in our environment and the challenges are 
many.
SASCI and funders
The CT angio project is currently under discussion at 
Discovery Health with input from SASCI (Graham Cassel). 
The objective of this programme will be to - at the very 
least - improve access of members to CT angio (without 
co-payment). In addition Mark Abelson is drafting a SASCI 
guidance document on FFR and IVUS for general distri-
bution to the funders with the objective of reducing post 
procedural paperwork. SASCI (Dave Kettles) will also 
support general availability of “covered stents” in the 
market and will request funders to allow use without 
undue paperwork afterwards.           
Private Practice Committee 
Len Steingo and Mark Abelson continue to work with SA 
Heart’s Private Practice Committee. SASCI envisages a 
workshop in the near future to consider (and advise 
members) on the appropriate claim codes to use in cases 
where existing codes do not cater for newer procedures.
Launch & programme of AfricaPCR at SA 
Heart 2012 congress 
AfricaPCR was officially announced by Prof Jean Marco 
during his opening address at the recent SA Heart con-
gress. The announcement was met with excitement and 
interest by both South African and African delegates. 
At the congress SASCI and PCR offered the first AfricaPCR 
programme (Friday 20 July). The launch was well received 
and standing room only was available. A world class 
international and local faculty was assembled and delegates 
were exposed to learning through the unique PCR teaching 
methods. 
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AfricaPCR course at WPCSSA 2013 
The 2nd AfricaPCR programme will be offered during the 
World Congress of Paediatric Cardiology in Cape Town 
(full day on 22 February). More details can be found 
elsewhere in this newsletter. I would like to thank PCR 
(Prof Jean Marco and William Wijns) for their continued 
support as well as our local PASCAR committee members. 
The AfricaPCR Board (appointed until 2015) has Farrel 
Hellig (SA) and William Wijns (Belgium) as Directors 
with Co-Directors Bernard Gersh (USA), Otieno Harun 
(Kenya), Sajidah Khan (SA), Tom Mabin (SA), Ganesh 
Manoharan (Ireland), Christoph Naber (Germany) and 
Mpiko Ntsekhe (SA). 
In addition to the AfricaPCR programme SASCI will be 
offering 2 breakfast symposia (21 & 22 February) with 
coronary disease content for the adult cardiologist in 
addition to the 5-day interventional track which is part of 
the World Congress. SASCI believes this congress will 
offer our members world class teaching over a broad 
spectrum and urge  you to attend. I would like to thank our 
designated representative Adie Horak for his contribution 
to the programme.    
SASCI’s track: “Catheter-based interventions from foetus 
to adult” will include live presentations augmented by a 
combination of lectures, debates, master classes and pre-
recorded cases spread over the five congress days. These 
cases will highlight more recent interventions such as 
transcatheter valve placements and atrial appendage 
ablations. Invitations have been extended to an excellent 
international faculty, and this promises to be a stimulating 
and exciting congress, which will cater for both adult  and 
paediatric cardiologists. 
Visiting professor programme
Unfortunately Prof Jean Marco (who would have been our 
3rd annual Visiting Professor) informed us that he will not 
be able to travel to South Africa in 2013. SASCI is currently 
exploring other possibilities and would like to thank 
Medtronic for their continued unconditional support of this 
important educational initiative. 
Opportunities for Fellows
Five South African Fellows had the opportunity to attend 
the European Society of Cardiology Congress (2012) for 
the 1st time! Feedback (see elsewhere in this newsletter) 
from Tawanda Butau (UCT/Groote Schuur), Nompumelelo 
Gogo (University of Limpopo/Medunsa), Parmanand Naran 
(Pretoria/Steve Biko), Pieter van der Bijl (Stellenbosch/
Tygerberg) and Siswe Mthiyane (Pretoria/Steve Biko) was 
very positive and all extended their appreciation to the 
ESC, SA Heart, SASCI and industry sponsors Winthrop, 
Pharma Dynamics, B Braun and Medtronic for making this 
educational initiative possible. SASCI hopes that this may 
become an annual programme. 
SASCI is proud to confirm that Dr Aine Mugabi is the 2012 
recipient of the RC Fraser International Fellowship in 
cardiovascular intervention award. Dr Mugabi will go to 
Dr Martyn Thomas (consultant cardiologist & clinical 
director for cardiovascular services unit) at Guys & 
St Thomas’ Hospital, London for one month in 2013 
where he will be able to expand his knowledge and 
further his abilities. This award is annually sponsored by 
Boston Scientific.
South African Fellows once again will have the opportu-
nity to attend the annual Society for Cardiac Angiography 
and Intervention (SCAI) Fellows Programme in Las Vegas 
(December 2012). The SA delegation for 2012 is 
G. Visagie (UFS), B. Cupido (UCT), S. Gafoor (IALH) and 
K. McCutcheon (JHB Gen). Boston Scientific sponsors the 
flights to Las Vegas and the SCAI offer includes registration, 
accommodation and meals during the programme. 
The 8th annual SASCI Fellows Programme will be held in 
Somerset West (Mediclinic Vergelegen Hospital) with 
Dr Mark Abelson as programme director. Please watch 
this space: dates will be confirmed soon. Please talk to 
Mark Abelson or George Nel if you would like to contri-
bute or attend.
Interventional Society of Cathlab Allied 
Professionals (ISCAP)
ISCAP: Please read the full report on activities elsewhere 
in this issue. Of note is that a number of regional 
educational meetings have already taken place for allieds 
and that a basic cathlab training manual will be available 
early in 2013. Well done to ISCAP’s steering committee!
Continued on page 306
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PRIVATE PRACTICE COMMITTEE
SA Heart’s Private Practice Committee (PPC) aims to 
optimise its representation of cardiac practitioners in the 
private sector and is working closely with SAMAs PPC to 
ensure a united and stronger voice. The PPC wants to 
represent as many practitioners as possible when interacting 
with medical funders and other stakeholders to ensure 
members are remunerated fairly and according to the high 
level of skill required to do their work. 
The PPC aims to update the Cardiology billing codes to 
keep up with the vast number of new procedures which are 
currently not listed and to adjust  inappropriate codes. The 
target is to have new codes ready for publication in the 
2014 SAMA Doctors’ Billing Manual. We have requested 
SA Heart’s special interest groups (SIGs) to assist as they 
know best which procedures require an update.          
The PPC has engaged the major funders to find the best 
outcomes for our members. We had several meetings with 
Discovery Health which yielded fruitful results as indicated 
in Dr Jankelow’s report. Discovery has also accepted our 
position to do away with filling out chronic forms. 
On a prescription page the following details need to be 
present: The patient’s name and surname; Medical Aid 
number; ICD 10 code; if the patient is hypertensive, the 
reading that diagnosed hypertension; and finally, the patient’s 
signature showing that he/she has given permission for his/
her medical information to be divulged. If the treatment is 
for dyslipidaemia and for primary prevention of CVDN, then 
the lipogram results should also be faxed. This should help 
reduce the administrative burden of a lot of doctors.  
A meeting with Medscheme’s Medical Adviser has paved 
the way for discussions similar to that with Discovery.                
It is worth repeating the words of caution put out by 
Dr Jankelow about the codes required for High Care 
(HCU)/ICU treatment; also what categorises one as an 
ICU or High Care patient, and to ensure that the hospital 
code is in agreement with the doctor’s code. Drs David 
Jankelow and Jean Vorster have volunteered and been 
tasked to deal with billing and coding queries from SA 
Heart members. They will also take up any issues with any 
funder as the need arises on behalf of the PPC. We would 
like to standardise the handling of these queries so that 
cardiac practice positions only come from our Association. 
The Private Practice Committee has had meetings with 
Discovery Health regarding coding, billing and we have 
created a forum whereby we can thrash out areas of 
difficulty. The lines of communication will remain open and 
they have enabled us to resolve important issues. We are 
having meetings with Medscheme at this point on the 
possible formation of a "Specialist Forum", also aimed at 
discussing problems and finding resolutions. 
We aim to continue to improve the practising environment 
for SA Heart members.                                             
Makoali Makotoko
Chairman, Private Practice Committee, SA Heart
SASCI NEWS continued
Council for Medical Schemes - TAVI 
SASCI currently has one of Tom Mabin’s cases on appeal 
after the CMS initially ruled “in favour” of the medical aid 
not funding TAVI as a PMB. Elsabe Klinck is supporting 
SASCI from a legal perspective and highlighted various 
areas of concern with the CMS ruling(s). The actual 
documentation is available on request. 
Acknowledgements
I would like to thank my hard-working executive and also 
our industry partners for their continued and unwaver-
ing support of SASCI and its constitutional objectives. 
These companies have demonstrated their commitment 
|to our Society and education in South Africa: Angio Quip, 
Aspen, AstraZeneca, Baroque, B Braun, Boehringer-
Ingelheim, Boston, Cipla Medpro, Cordis, Disa Vascular, 
Edwards, Medtronic, Paragmed, Pharma Dynamics, Surgical 
Innovations, Torque Medical, Viking, 
Volcano and Winthrop.
Please contact your Executive Officer 
George Nel at 083 458 5954 or 
sasci@sasci.co.za if you need assis-
tance in any way or want to formally 
communicate with the executive. 
Farrel Hellig
President, SASCI
South African 
Society of 
Cardiovascular 
Intervention
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REPORT ON ESC MEETING, 25 - 29 AUGUST 2012
I’m most grateful to SASCI and SA Heart for being afforded the opportunity to attend such a large-scale congress. It was a 
great privilege to listen to prominent figures in cardiology presenting their research work. Listening to Dr E. Braunwald and 
other well-known names in the world of cardiology “in the flesh” was actually a great experience and learning opportunity. 
Many symposia took place where topics were succinctly presented from basic science to clinical application by world 
authorities in the various sub-disciplines of cardiology. I also had the opportunity to listen to some of the members of the 
working groups drafting the ESC guidelines and hear cardiologists from all over the world comment and criticise their 
recommendations. Overall, it was a thoroughly enriching academic experience which I hope will be availed to other fellows 
in the future.
Dr Tawanda Butau
THIRD UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION 
My sincerest thanks to SA Heart and Medtronic for the 
once in a lifetime opportunity to attend the ESC congress. 
It truly was an eye opener. Interesting topics were discussed 
and the third definition of myocardial infarction has been 
one among many. 
The overall pathological definition of myocardial infarction 
remains as myocardial cells a result of prolonged ischaemia, 
with the definition applicable in any of 5 types:
TYPE 1: Spontaneous myocardial infarction
Related to atherosclerotic plaque rupture, ulceration, 
fissuring, erosion or dissection with resulting intraluminal 
thrombus in one or more of the coronary arteries leading 
to decreased myocardial blood flow or distal platelet 
emboli with ensuing myocyte necrosis.
TYPE 2: Myocardial infarction secondary to 
an ischaemic imbalance
In instances of myocardial injury with necrosis where a 
condition other than Coronary Artery Disease contributes 
to an imbalance between myocardial oxygen supply and/or 
demand, for example coronary endothelial dysfunction, 
coronary artery spasm, coronary embolism or anaemia.
TYPE 3: Myocardial infarction resulting in 
death when biomarker values are unavailable
Cardiac death with symptoms suggestive of myocardial 
ischaemia and presumed new ischaemic ECG changes or 
new Left Bundle Branch Block, but death occurring before 
blood samples could be obtained, before cardiac marker 
could rise or, in rare instances, cardiac biomarkers were 
not collected.
TYPE 4a: Myocardial Infarction related to 
Percutaneous Coronary Intervention (PCI)
It is defined by elevation of cardiac Troponin values >5 
x 99th percentile Upper Reference Limit (URL) in patients 
with normal baseline values or a rise of cardiac troponins 
values >20% if the baseline values are elevated.
TYPE 4b: Myocardial infarction related to 
stent thrombosis
It is detected by coronary angiography or autopsy.
TYPE 5: Myocardial infarction related to 
coronary artery bypass grafting (CABG)
It is defined by elevation of cardiac troponins >10 x 99th 
URL. In this latest definition the concept of myocardial 
infarction has not changed but the diagnosis is based on 
patient symptoms, ECG changes, highly sensitive biomarkers 
and information gleaned from various imaging techniques.
Additional information applies to PCI, CABG, cardiac and 
non-cardiac surgery and in clinical trials where myocardial 
infarction can be used as either an entry criterion or as an 
end-point. 
Dr Nonpumelelo Gogo
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6TH INTERNATIONAL CONGRESS OF THE AFRICAN ASSOCIATION 
OF PHYSIOLOGICAL SCIENCES
I submitted an abstract on part of the research for my 
Masters degree about the role of STAT3 and progression 
of heart failure with age in mice to the 6th International 
Congress of the African Association of Physiological 
Sciences (AAPS) in Ismailia, Egypt from 1 - 5 September 
this year. The conference showcased research carried out 
by African doctors addressing health and science topics 
relevant to Africa and included keynote lectures from 
speakers from Japan, Britain, Pakistan, Finland and the USA.
I requested a poster presentation and was instead invited 
to give a 20 minute oral presentation during the opening 
session. It was my first time presenting (much less to an 
international audience) but it went off very smoothly and 
was well received. I was congratulated by several senior 
scientists including Prof David Eisner. He serves on the 
editorial boards of Basic Research in Cardiology, Cell 
Calcium and Experimental Physiology. He is a senior 
consulting editor of Circulation Research and the editor-in-
chief of The Journal of Molecular and Cellular Cardiology 
one of the major journals in my field. I was also approached 
by some of the attending scientists including Dr Yasser El 
Wazir from the University of Cairo, Dr Prem Gathiram 
from the University of KwaZulu-Natal and Dr Saartjie Roux 
from the Nelson Mandela Metropolitan University who 
requested we keep in touch and perhaps see about working 
on joint projects later on. 
The poster and oral presentations covered a multitude of 
topics from the use of gum Arabic to better health 
outcomes to the dangers of having electro-magnetic equip-
ment such as cell phones and laptops too close to the 
body. One of the lectures I found most intriguing was 
delivered by Dr Akimichi Kaneko of Japan, it was titled: 
The retinal mechanism of visual contrast enhancement. 
He spoke about the mechanism of sight and cells involved 
in the transmission of visual signals in the eye and how 
they cooperate to give rise to real time visual recognition. 
It was fascinating. 
Two prominent topics were heart/vascular research and 
research related to pulmonary function – problems which 
are common here in Africa. The content covered was of a 
good quality and much of the data presented held promise 
for further extrapolation or clinical application. 
The conference proved to be a fantastic opportunity to 
network; not only to meet other researchers in Africa, but 
also to extend a hand to work together and form a closer-
knit community. 
In South Africa we are blessed when it comes to our 
resources compared to the other African countries. We 
have far easier access to facilities that we need for research, 
and building bridges with other scientists in nearby coun-
tries would step up research output not only for us, but for 
them too. It was a fantastic atmosphere, each day started 
early and ended late with talking to other people there 
who were enthusiastic and such a delight to be with. 
The conference was comparatively small as the AAPS is 
still in its elementary phase of growth but, having heard 
what people had to say at and about the conference, I am 
sure it will grow with time. It was a pleasure to attend and 
present at this conference and I am truly grateful for the 
opportunity to have attended. I would like to express my 
heart-felt gratitude to the South African Heart Association 
for its support which made my attendance possible. 
Aqeela Imamdin
Ms Aqeela Imamdin (front, second from left) won the 
SA Heart travel scholarship for the second term in 
2012 and attended the 66th International Congress 
of the African Association of Physiological Sciences 
in Egypt.
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FULL TIME SALARIED COMMITTEE TACKLES VARIOUS MATTERS
14TH ANNUAL CONGRESS OF THE SOUTH AFRICAN HEART ASSOCIATION
17 - 22 FEBRUARY 2013, CAPE TOWN, SOUTH AFRICA
Prof Andrew Sarkin reports that his committee now meets regularly and is in the process to investigate and draw up a 
proposal to industry regarding ways to effectively support full time public service cardiac care for mutual benefit.
Eastern Cape doctors were facing disciplinary action as a result of raising concerns. We wrote a letter on behalf of SA Heart 
indicating that this appeared counter-productive and it now seems that all of the charges have been dropped.
With regards to the National Health Initiative (NHI) policy statement, Prof Sarkin has been working on this together with 
Dr Mokali Mokotoko and Prof Francis Smit.  
Prof Sarkin and his team on the full time committee, together with SA Heart is preparing a booklet setting out guidelines for 
basic treatment and referral of patients (taking into account our circumstances) with specific diseases primarily for use in the 
secondary and district hospitals. 
Obviously, each department has its own specific approach but the generalities of a disease are the same. It is not aimed to 
set out the ideal, first world care, but the realities of what is achievable within our existing system. The aim is to set out what 
we can expect and what we can do to empower our referral hospitals. Baragwanath is in the process of preparing such a 
guideline in relation to ST elevation MI.
Join us for exciting sessions with world 
leaders on:
 ■  Cardiac intervention: Filled with live cases from 4 
different centres together with state-of-the-art lectures 
by experts in their fields.
 ■  Healthy hearts, exercise physiology and sudden death: 
We will highlight interventions, management and suc-
cesses while focusing on new trends in lifestyle man-
agement and appropriate treatment of hyperlipidaemia. 
Learn about the limits of human endurance, physical 
activity for those with established heart disease and 
look at screening of athletes both competitively and at 
school level. Finally a unique summit of Sudden Death 
interest groups will be a “don’t-miss” for those working 
in this field
 ■  AfricaPCR: AfricaPCR is a collaborative initiative be-
tween SA Heart, the South African Society for Cardio-
vascular Interventions (SASCI), PASCAR, PCR and 
EUROPA (which organises the popular EUROPCR 
meetings). AfricaPCR is a course with the primary role 
of education in Interventional Cardiovascular Medicine. 
The focus is on learning techniques, practical skills and 
transfer of knowledge, experience and practice through 
case based discussions. The 2nd annual AfricaPCR 
course will be offered on Friday 22 February as part of 
this congress.
 ■  Adults with congenital heart disease: The complexity 
of dealing with congenital heart disease in the adult, 
juxtaposed with coronary artery and degenerative heart 
disease is a focus in several sessions. Experts review 
management of these patients, options for improved 
outcomes and highlighting important issues such as 
contraception, modes of delivery for pregnant women 
with ACHD and impact of congenital heart disease on 
general cardiovascular health.
 ■  This and much more will be on offer during the 14th 
Annual Congress of the South African Heart Asso-
ciation in Cape Town from 17-22 February 2013. 
Please note that the annual congress has been moved 
forward to coincide with the WCPCCS happening at 
the same time. 
Register and view the full programme on the website 
of WCPCCS, who is coordinating this congress for 
SA Heart. http://wcpccs2013.co.za
6th
Paediatric Cardiology & Cardiac Surgery
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SA HEART 2012 CONGRESS: FEEDBACK
Applied Sciences workshop
The workshop was reasonably well attended throughout 
the day with between 20 and 40 participants at each 
presentation. Active participation from the audience was 
evident. The aim of the workshop was to explore the 
scientific rationale/biochemical basis for, as well as patho-
genesis relating to: 
 ■   Cardiac biomarkers and radiographic investigations; 
 ■   Specific treatment options; 
 ■   Cardiomyopathies and conduction disorders; and
 ■   Myocardial necrosis in the animal model.
Comments
 ■    The presentations by, and contributions of the 2 
international speakers to discussions added “depth” to 
the workshop.  
 ■    The title of the workshop may have been misleading as 
only one paper resulted from research in the “Basic 
Sciences”.
 ■    The topics appeared to have solicited interest and 
discussion.
 ■    The contributions from non-cardiologist disciplines 
(pathology, radiology and pharmacology) should pro-
bably have been better informed by cardiologists’ 
needs/expectations however, the audience did not 
constitute mainly cardiologists.
 ■    The need for a Basic (Applied) Sciences workshop 
should be explored where scientific/methodological 
expertise is shared across the spectrum of preventative 
cardiology (dietetics, lifestyle, etc.), laboratory (genetic 
or biochemical cardiac markers) or clinical/experi-
mental (animal and human) research.
 ■    The need for a Scientific Update session should be 
investigated.
Abstracts
A total of 54 abstracts were accepted for the conference, 
32 as poster presentations and the rest as platform 
presentations. Twelve of the platform presentations and 
20 of the poster presentations were clinical.   
Three abstracts were not deemed suitable for publication 
in the SA Heart. No re-submissions were received for 
these 3 submissions following request for revision. Authors 
were allowed to present the papers as posters and were 
requested to consider comments for improvement. 
An instrument was devised to guide the adjudication for 
the awards. 
The willingness of all evaluators and adjudicators to 
contribute as experts to the scientific level of excellence of 
the conference is gratefully acknowledged. 
Comments and suggestions
Scientific contributions from local and international 
researchers should be encouraged and show-cased to 
promote research nationally and to ensure the scientific 
integrity of our Society.
The administrative workload of managing abstract 
submissions, evaluations and adjudications for awards 
warrant the designation of a chairperson and team.
The continual electronic display of the posters appeared to 
work well as did the prize for the most favourite poster 
and the draw for the correct identification of the best 
poster as identified by the adjudicators. 
 ■    Deadlines for submissions should be honoured – late 
submissions lead to an increased administrative burden 
and also to inconsistence in appraisal.
 ■    Pre-screening of the scientific format and adequacy 
upon submission, and timely rebuttal prior to distri-
bution amongst evaluators is imperative.
 ■    Evaluators from different interest groups should be 
contracted well in advance with clear guidelines for 
provisional acceptance as either poster or platform 
presentations.
 ■    Adjudicators for the different interest group posters/
platform presentations should be contracted well in 
advance with clear guidelines on recognition of 
excellence.
 ■    The policy for recognising and awarding excellence 
should be well thought through and transparent to all 
concerned.
 ■    Industry may be invited to sponsor interest-group-
specific awards, e.g. sponsorship of a conference. SA 
Heart may consider sponsoring the best poster 
award(s). 
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Feedback from industry via email
 ■    Delegates and trade commented on the congress 
being different (in a positive way).
 ■    Some complaints from trade about low number of 
cardiologists. This is seen as a “problem” every year. 
 ■    The meeting was well arranged. It is becoming very 
expensive for companies to attend these meetings. 
 ■    One of the best SAHA meetings I have attended, good 
value for money. I would like to say however that the 
“gala” dinner should be questioned, I am not sure that 
the money could not be better spent some other way. 
It costs a fortune and adds little value. The industry 
pays the bill, but very often there is no space for us. 
Another point is that some companies don’t exhibit 
but still attend the meeting, not sure if this is really fair. 
Comments, recommendations on 
international speakers
 ■   The speakers were very good as always. 
 ■   Great quality speakers.
Venue
 ■   Only positive feedback.
 ■    Suggested the need for a “map” on back of delegate’s 
name tag.
 ■    Sun City is getting old, it needs a revamp. It is a nice 
venue though, as it keeps attendees near the 
conference centre and we have more opportunity to 
interact with them. Places like Cape Town do not 
allow for this.
 ■    Sun City is a great venue, in my eyes the meeting 
should be held at the same venue every year, this will 
help curtail costs. Venue costs come down. Most 
delegates are from Gauteng, so the costs are kept 
under control.
Programme
 ■    Great. Not much needed to improve on. Always nice 
to have some of our speciality products discussed.
 ■    Programme was great; I heard a lot of really strong 
feedback from delegates, great faculty as well. 
AfricaPCR was a truly amazing session; people say 
should have been longer. One issue that was a 
problem, was taking the breakaways to different hotels 
which meant one could not just pop from 1 room to 
another if one wished to. It also diluted traffic to trade 
exhibitions.
Breakfast sessions
 ■   No comment.
 ■   Did not attend any.
Industry
 ■    As stated it is becoming excessively expensive to 
attend ALL the meetings. We need to consolidate and 
decide what is important and what is a nice to have. 
The industry always attends these meetings well.
 ■    Sun City is a great venue, costs are manageable and 
the venue works. People are safe. We don’t lose as 
same many delegates at Sun City as everyone stays at 
the same venue. 
The deal for international speakers and our 
local speakers
 ■    I do think that our local speakers are as good as most 
of the international speakers.
 ■    Local speakers get better every year; we don’t have to 
stand back.
A photographer and a congress report
 ■   I don’t think it’s necessary. 
 ■   Too much money little value.
Central Congress Organising Committee  
(CCOC)
What do you think of SA Heart’s idea that a Central 
Congress Organising Committee be formed out of our 
Exco which takes responsibility for the finances and 
logistic and the regions in turn – with involvement of all 
groups – to organise the scientific content?
 ■    I support the idea, the more you do something, the 
better and easier it gets, thus improving every time, 
same for the venue.
Continued on page 312
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SA HEART 2012 CONGRESS continued
Trade conference evaluation form
1. Have your expectations for the SA Heart 2012 Congress been met? 
 Not at all   Partly   Completely
       
 JJ  J      J   JJJJ
2. Were you satisfied with the exposure you were provided with, to the delegates? 
 Not at all   Partly   Completely
       
  J  JJ     JJ   JJ
3. Were you satisfied with the breadth of health professionals you were exposed to? 
 Not at all   Partly   Completely
       
     JJJJ    JJ   J
4.  Were all details relating to the trade setup and sponsorship opportunities communicated to you in a timeous 
and satisfactory manner? 
 Poor   Average   Great
       
     JJJJ JJ J
5. Do you believe that you received value-for-money at this congress? 
 Poor   Average   Great
       
  J   JJ    JJ   JJ J 
6. Please rate Sun City as a venue for future SA Heart congresses 
 Poor   Average   Great
       
  J   JJ    JJ   J JJ
7. Please rate the food at Sun City 
 Poor   Average   Great
       
    JJ JJJ   JJ
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8. How would you rate the cocktail function held on Thursday, 19 July? 
 Poor   Average   Great
       
  J J  J    J   JJJ J
9. How would you rate the SA Heart Congress Dinner held on Saturday, 21 July? 
 Poor   Average   Great
       
     JJ    JJ   J
10. How would you rate the topics in the main programme? 
 Poor   Average   Great
       
     J JJJJ    J
11.  How would you rate the PCO congress organisers: Londocor? 
 Very poor   Average   Very good
       
  Organisation skills    J  JJJJJ JJ
  Professionalism     JJ JJ JJJJ
  Communication re:     J JJ J JJJJ
  your requirements?
  Exhibition    J  JJJJ JJJ
Do you have any suggestions/feedback for 
future SA Heart Congresses (topics, speakers, 
PCO etc.)?
 ■    I was more than happy with Londocor’s organisation of 
the congress.
 ■    In terms of value to us - and a concern expressed prior 
to the 2012 event – in that our target audience, 
the top guys are not the ones coming to the stands, 
but rather the nursing sisters who come and interact 
with us.
 ■    High cost and low visibility/interaction by/with KOLs 
will lead to us evaluating if our participation in future 
SA Heart congresses warrants this kind of investment. 
By no means a reflection on Londocor but rather the 
low level of interaction with key customers.
 ■    Sorry but I am not a fan of Sun City. It is too expensive 
and far away for logistics, and too many medical 
congresses are held there every year. No competition 
allows them to load prices: R1 500 for a cabana room 
is too high, the restaurants are limited and it only has 
one entertainment venue Traders. The pool bars close 
at 17h00. I do not see why - when we pay so much for 
the stands - that drinks for the cocktail function cannot 
 
Continued on page 314
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SA HEART 2012 CONGRESS continued
be provided by the congress. The date being so close 
to ESC meant less delegates. There were very few 
Cape Town delegates.
 ■    Tea breaks should be restricted to exhibition areas 
only to ensure maximum exposure for exhibitors.
 ■    This SA Heart was not attended by as many doctors as 
in the past.  
 ■    Many doctors got “stuck” in the first section of the 
exhibition hall and never made it round to all the 
stands.
 ■    The opening evening or cocktail evening has been the 
same for many years now - how about a change - do 
something different?   
 ■    I was a bit late ordering my wine and in the end Sun 
City said no go - buy your own and pay corkage - not 
very flexible. I bought my own and, ended up not 
paying corkage!  
International speakers
 ■    It was my pleasure and honour to be able to participate 
at your annual conference. It was a pity I had to return 
to London last Saturday, but I look forward to visiting 
South Africa again. Mr Victor T. Tsang, Consultant Car-
diothoracic Surgeon, Great Ormond Street Hospital.
 ■    Once again it was a privilege to be invited and to 
spend time with all of our wonderful colleagues in 
South Africa! It was a great meeting, and I truly enjoyed 
all aspects: our “Mayo” symposium, the plenary and 
the congenital sessions. The safari trip after the 
congress was so amazing, please know we are very 
thankful for the kind and gracious hospitality and the 
chance to visit and form friendships after the congress. 
Allison (and Jeff) Cabalka
 ■   Thank you very much. Jean Marco
 ■    Baie dankie vir al jou reëlings. Die kongres was 
ongelooflik goed georganiseer en dit was vir my ’n 
groot voorreg om as spreker op te tree. Dankie ook 
vir die bederf na die kongres by die Lodge. Groete uit 
’n (voorlopig) sonnige België. Dr Derize Boshoff
 ■    I thoroughly enjoyed my brief visit to your wonderful 
country which is filled with beautiful people. I am 
pleased our educational offerings were well received. 
You all are to be congratulated on organising and 
conducting a great annual meeting. Prof. Paul Julsrud
 ■    It was indeed a great experience for all of us. I enjoyed 
my stay quite a bit thanks to the great hospitality. The 
conference was very well attended and it was nice to 
hear other speakers. There is no question South Africa 
won my heart. It was a very memorable trip. You all 
should be commended for the wonderful job and 
preparation. Very, very well done. Dr Naser Ammash
 ■    I have had a wonderful time in South Africa and 
enjoyed meeting all the delegates. You did a marvellous 
job organising the meeting. We have set up several 
collaborations with investigators in Pretoria and Cape 
Town. I look forward to seeing you again on future 
visits to South Africa. Prof Leslie Cooper
 ■    I thank you and the organising committee for the 
opportunity to participate in the SA Heart Congress. 
It is a real privilege for me to be able to do that 
and you have always made my colleagues and I feel 
very welcomed and we always enjoy the trip there. 
Thanks again and I do appreciate your message. 
Vuyisile Nkomo
 ■    Many thanks. Was a great meeting both scientifically 
and socially. Look forward to returning sometime. 
Very best. David Taggart, Prof of Cardiovascular 
Surgery, University of Oxford.
 ■    The meeting was great and the interchange with the 
speakers and the delegates was wonderful. Thanks for 
the chance and for all of your help. David  Holmes
 ■    I had a great time. I gather that Ivory tree was also a 
huge success as was the Saturday night gala. I thought 
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that that the entire meeting was of a very high standard 
and so pleased to be involved. Bernard Gersh
 ■    Thank you. You did a wonderful job and the meeting 
was great. We had a great time in South Africa! 
Dr Norman Silverman
 ■    Thank you for your invitation, your overwhelming 
hospitality and the great organisation you did. It was a 
great meeting in a great country. I hope to see you 
soon in Germany or South Africa. Dr Roland Tilz
 ■    Spectacular meeting! Perfectly timed to the victory of 
my rugby team (Sharks), SA cricket team and Ernie! 
Michael D. Ezekowitz
Comments by Dr Snyders
 ■    Some academics were unhappy that the congress did 
not provide more financial support for fellows to 
present their research. In the past tertiary institutions 
used their own research funds for that purpose – it 
seems that these funds are not readily available any 
longer?
 ■   International speakers should give at least 4 talks.
 ■    Consider adding an ESC Guideline 1-day session: ESC 
will most probably sponsor speakers’ travel cost and 
congress will have to sponsor accommodation costs.
 ■    Gala dinners are not allowed at congresses in Europe 
and USA: Do we need that? At SA Heart Congress 
delegates pay an additional fee for this event (which is 
optional) and therefore it does not necessarily impact 
on the profit. Entertainment expenses for this year’s 
congress were also lower than previous years.
 ■    Investigate a Hypertension Day and invite Hyper-
tension Society to run the programme.
 ■   I understand the surgeons are still unhappy?
 ■    Despite their criticism, the industry did not offer much 
in line of useful advice or help.
 ■    Industry that complained the most were also the ones 
that contributed and participated least and are the 
same ones that complain every year.
 ■    Keep in mind that AfricaPCR may not be part of SA 
Heart Congress in future though there will always be 
a SASCI programme. AfricaPCR will also be held in 
other African countries.
 ■    We need to continue to analyse money wastage: the 
huge cost of building stands can probably be used 
more efficiently. Do we need stands? Would an 
exhibition area not suffice where industry builds 
smaller stands or supply pull-up banners only? This 
needs to be discussed with industry.
 ■    The 2012 SA Heart Congress is over, but we have 
time (with our central congress organising committee) 
to discuss the way forward for 2013 and future 
congresses. We should continue to liaise with the 
industry, academics and, most importantly, our 
members to identify needs.
Attendee analysis
We’ve not had time to give a break-down on registered 
doctors for the 2009 and 2011 congresses. For the 2012 
congress (a total of 978 delegates were registered), we 
can report the following registration figures:
 ■    301 medical professionals (adults & paediatric 
cardiologists, cardiothoracic surgeons and others 
(i.e. anaesthetists, general practitioners, specialist 
physicians). (The numbers exclude the pre-congress 
workshops);
 ■    367 allied professionals (nurses, perfusionists, tech-
nologists and others); and
 ■   310 trade delegates.
Last but not least, it was disturbing to see how many of 
prominent attendees only paid their SA Heart membership 
at the Congress – thus not leading by example.
Adriaan Snyders
Chairman 2012 COC
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 PAEDIATRIC CARDIAC SOCIETY OF SOUTH AFRICA
Programme for PCCSA World Congress
The Paediatric Cardiac Society of South Africa‘s (PCSSA) 
main objective is to improve the quality of care for children 
with congenital and acquired heart disease by promoting 
research and supporting education and training of heart 
specialists. The PCSSA is also the primary advocacy group 
for children with heart disease in South Africa. Membership 
is open and we actively encourage participation from 
colleagues in Africa as well as interaction with special 
interest groups.
Our new Exco was elected at the recent SA Heart meeting 
and they will serve until 2014. The executive consists of:
Liesl Zühlke  President
Paul Adams  Vice-president and public service
Jeff Harrisberg  Private practice
Stephen Brown  Treasurer
Lindy Mitchell  Secretary
Andre Brooks  Education
Ebrahim Hoosen  Ex-officio and ethics
Christopher  CEO of the 2013 congress company
Hugo-Hamman 
The new executive is excited to be at the helm of the 
Society over the next 24 months, which promises to be 
extremely productive indeed.
Important 2012 events 
PCCA Symposium
The 5th Annual Symposium of the Paediatric Cardiac 
Centre for Africa (PCCA) was held on March 30th and 
31st at Sandton’s Netcare Auditorium with prominent 
surgeons David Barron, Tom Spray and John Brown on the 
guest list. The meeting, convened by Rob Kingsley,  was 
interesting and engaging and provided an opportunity to 
hear from leading international faculty in an informal 
setting.  
SA Heart Congress 2012
With Lindy Mitchell and her organising team at the helm, 
an excellent programme was held with guests including 
former South African Derize Boshoff of Belgium, Victor 
Tsang from the UK and Norman Silverman from the US 
this year. These eminent clinicians held several riveting 
sessions filled with debate and comprehensive information. 
A pre-congress workshop entitled “Tetralogy of Fallot 
from Child to Adult” was an excellent start to the paediatric 
programme, followed by focused sessions on the evaluation 
and management of Hypertrophic Cardiomyopathy, Atrio-
ventricular Septal Defects, Ebstein Anomaly and Hypo-
plastic Left Heart Syndrome. A session on “Nightmare 
cases in the cathlab” as well as interactive sessions made 
for an outstanding programme. Congratulations to Lindy 
and her team for the success following your incredible 
hard work and thanks to our international and national 
speakers. We also want to congratulate our fellows who 
presented and indeed won some of the prizes this year. 
The prize for the favourite e-poster went to Dr Himal 
Dama, a fellow from Inkosi Albert Luthuli.
We are mere 
months away from 
hosting the largest 
ever cardio-
vascular event 
on the continent 
of Africa!
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We are mere months away from hosting the largest ever 
cardiovascular event on the continent of Africa! This is 
truly a remarkable opportunity to showcase the progress 
made in congenital heart disease (CHD) over the past 
decades, meet the absolute experts in the field and 
welcome international faculty and returning friends to our 
country. However, it is also an opportunity for adult 
cardiology colleagues to enjoy some ground-breaking and 
relevant scientific sessions. Indeed, the child is the father of 
the man.
Africa PCR
AfricaPCR is a collaborative initiative between the South 
African Society for Cardiovascular Interventions (SASCI), 
SA Heart, PASCAR and EUROPA (which organises the 
popular EUROPCR meetings). AfricaPCR is a course with 
the primary role of education in Interventional Cardio-
vascular Medicine (ICM) and the 2nd annual AfricaPCR 
course will be held on Friday, 22 February at the World 
Congress of Paediatric Cardiology and Cardiac Surgery. 
The programme will include “AfricaPCR Case Corner”, 
Interventional medicine for pericardial and valvular disease. 
The focus remains on learning techniques, practical skills 
and interactive case discussions. 
Catheter interventions from foetus to adult
This track promises to be extremely exciting for paediatric 
cardiologists and adult cardiologists managing atrial 
fibrillation and degenerative aortic valve disease alike. 
There will be live cases from 4 different centres with state-
of-the-art lectures by experts in their fields of interest. 
Approximately 25 - 30 live cases will be transmitted 
directly to the lecture hall in the course of 4 days from 
Frankfurt, Germany (Horst Sievert) and Milano, Italy (Mario 
Carminati). The 2 local, South African centres transmitting 
live cases will be Sunninghill clinic in Johannesburg and the 
Chris Barnard Memorial Hospital in Cape Town.
The live cases will focus on structural congenital cardiac 
defects in both children and adults. Cases planned include 
VSD closures, occlusion of left atrial appendage, complex 
pulmonary artery and coarctation stenting as well as 
percutaneous pulmonary and aortic valve implantations. 
6th
Paediatric Cardiology & Cardiac Surgery
Continued on page 318
New on our website!
An extremely exciting development in our Society has 
been the fact that we have secured access to Pedheart 
Resource - the most comprehensive educational website 
on congenital heart disease. It has detailed defect and 
treatment descriptions, in-depth tutorials, a searchable 
image library, collections of patients’ hand-outs and over 
1200 PowerPoint slides in several different languages. 
(http://www.heartpassport.com/)  
In addition, PCSSA now has a site providing information 
on congenital heart disease for both parents 
(http://www.africa.congenital.org/), and medical practi-
tioners. Links to both these sites can be found on PCSSA’s 
home page  (http://www.saheart.org/pcssa/). Access to the 
parent information site is available to everyone, but only 
paid-up PCSSA members have access to the medical 
practitioner site. 
Important events for 2013
6th World Congress of Paediatric 
Cardiology and Cardiac Surgery, 
Cape Town 17 - 22 February 2013
My heart leaps up when I behold
My heart leaps up when I behold
A rainbow in the sky:
So was it when my life began;
So is it now I am a man;
So be it when I shall grow old,
Or let me die!
The Child is father of the Man;
I could wish my days to be
Bound each to each by natural piety
William Wordsworth, 1802
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PCCSA continued
There will be many topics of interest for adult cardiologists, 
including transcatheter aortic valve implantation, PFO 
controversies, occlusion of left atrial appendage and 
management of complex aortic coarctation.
Adults with congenital heart disease
Whilst congenital heart disease (CHD) has long been 
regarded as a “paediatric” domain, there are now more 
adults in the more well-resourced nations living with CHD 
than there are children. The complexities of dealing with 
CHD in the adult, juxtaposed with coronary artery and 
degenerative heart disease, will be a focus in several of the 
sessions. We will be reviewing management of these 
patients and options for improved outcomes and also 
highlight important issues such as contraception, modes of 
delivery for pregnant women and look at the impact of 
CHD on cardiovascular health. 
Healthy hearts, exercise physiology and sudden death
Preventative cardiology, risk reduction and the promotion 
of healthier lifestyles through exercise and better nutrition 
is quite obviously an indivisible science as these antece-
dents of adult onset heart disease already occur - and have 
to be prevented - in children. Cardiovascular disease now 
causes over 80% of deaths in the world with the greatest 
increase occurring in Africa. We will highlight interven-
tions, management and successes while focusing on new 
trends in lifestyle management and appropriate treatment 
of lipidaemias. Healthy hearts imply a healthier lifestyle and 
increased activity. Sessions will unpack the limits of human 
endurance, physical activity for those with established 
heart disease and look at screening of athletes both 
competitively and at school level. Finally a unique summit 
of Sudden Death interest groups will be a “don’t-miss” for 
those working in this field.
Computational technology and the latest in 3- and 4-D 
imaging, MRI and CR reconstructions
Finally, all of us enjoy new technologies and this confer-
ence will showcase the newest and latest in computa-
tional technology and imaging. Some of the world’s 
experts in echo will be available to share insights into the 
uses (and abuses!) of these technologies and astound 
you with their capabilities and its potential impact on 
patient care. 
Please use this opportunity to register for the congress and 
view the faculty and programme on our website at 
http://wcpccs2013.co.za/
To all the regular PCSSA members - we encourage you to 
be active in our society - and look forward to receiving 
your suggestions and new ideas. This is going to be a 
remarkable year for our Society and SA Heart as we host 
the world congress together. We as the new executive 
look forward to seeing you at upcoming events and wish 
you all the best for the rest of the year. 
Contact details
President:  Liesl Zühlke liesl.zuhlke@uct.ac.za
Secretary:  Belinda Mitchell lindy.mitchell@up.ac.za
Kind regards to all and see you at the World Congress!
Liesl Zühlke
Healthy hearts 
imply a healthier lifestyle and 
increased activity.
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CONTENT-RICH PCCS WORLD CONGRESS SOON IN CAPE TOWN 
4... 3... 2... 1...! 
With just 4 months to go before the 6th World Congress 
of Paediatric Cardiology and Cardiac Surgery (PCCS) the 
countdown to 17 February has begun in earnest.
Our October newsletter aims to answer a question many 
may, at first glance, regard as a little out of place at a con-
ference for paediatric cardiology: What’s in it for adult 
cardiologists and adults with heart disease? The answer is 
“a lot”. Some time back the organisers recognised the need 
for a programme with “adult” content. The reasons are 
3-fold: 
 ■    Firstly, in all heart disease from heart failure (HF) to 
rheumatic heart disease (RHD) and interventions the 
scientific separation of “paediatric” and “adult” is 
based on an arbitrary genealogical end-point which is 
regarded as outdated and inappropriate by many; 
 ■    Secondly, while congenital heart disease (CHD) has 
long been regarded as “paediatric” domain the number 
of adults living with CHD exceed that of children in 
more well-resourced nations. The message is that 
cardiologists ignore CHD at their patient’s peril; and
 ■    Finally, preventative cardiology, risk reduction and 
healthier lifestyle promotion through exercise and 
better nutrition is obviously an indivisible science in 
preventing adult onset heart disease  in children and 
for managing CHD in adults.
The intervention track
This track promises to be the one of the most exciting and 
is filled with live cases from 4 different centres. State-of-
the-art lectures by experts in their fields of interest will 
furthermore prove informative to both paediatric and 
adult cardiologists managing grown-up congenital heart 
(GUCH) patients, atrial fibrillation and degenerative aortic 
valve disease.
Adults with congenital heart disease
As William Wordsworth said in his famous 1802 poem, My 
Heart leaps When I Behold: “The Child is father of the 
Man”. The complexity of dealing with ACHD  juxtaposed 
with coronary artery and degenerative heart disease is a 
focus in several sessions. Experts review the management 
of these patients, look at options for improved outcomes, 
highlight important issues such as contraception, modes of 
delivery for pregnant women with ACHD and discuss the 
impact of CHD on general cardiovascular health.
Healthy hearts, exercise physiology and 
sudden death
Cardiovascular disease now causes over 80% of deaths in 
the world with the greatest increase in deaths occurring in 
Africa. We will highlight interventions, management and 
successes while focusing on new trends in lifestyle manage-
ment and appropriate treatment of hyperlipidaemia. 
Healthy hearts imply a healthier lifestyle and increased 
activity. Sessions will unpack the limits of human endurance, 
physical activity for those with established heart disease 
and will also look at the screening of athletes both compe-
titively and at school level. Finally a unique discussion of 
Sudden Death by interest groups will be a “don’t miss” for 
those working in this field.
AfricaPCR
AfricaPCR is a collaborative initiative between SA Heart, 
the South African Society for Cardiovascular Interventions 
(SASCI), PASCAR, PCR and EUROPA (which organises 
the popular EUROPCR meetings). AfricaPCR is a course 
with the primary role of education in Interventional Car-
diovascular Medicine. The focus is on learning techniques, 
practical skills and transfer of knowledge, experience and 
practice through case-based discussions. The 2nd annual 
AfricaPCR course will be offered on Friday, 22 February as 
part of the PCCS world congress.
I speak for all the members of the organising committee 
when I say that we are determined to ensure that when we 
meet on the African continent it will be most memorable. 
I am inspired when I look at the list of 284 world leaders in 
surgery and cardiology who have already joined our 
Faculty. And have good reason to believe that this Faculty 
will continue to grow. 
The number of delegates is growing rapidly as well, with 
over 725 delegates from 61 countries already registered. If 
you have not registered yet, you still have a chance to 
book.  
Finally, our website has practical information for foreign 
delegates at www.wcpccs2013.co.za Aspects relating to 
visas, accommodation, transport, shopping, wining & dining 
and special offers are all covered here. 
4...3...2...1... see you in Cape Town soon!
Christopher Hugo-Hamman
Chairman, 6th World Congress Paediatric Cardiology & 
Cardiac Surgery 2013
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HEART AND STROKE FOUNDATION SOUTH AFRICA
Heart awareness “know your numbers”
September 2012’s Heart Awareness Month was an 
extremely busy time for the Heart and Stroke Foundation 
(HSF). One of our key messages to the public was to 
“know your numbers” – that is cholesterol, blood glucose, 
blood pressure and body mass index. To this end, we held 
12 free screenings in 4 locations around the country 
(Gauteng, Cape Town, KwaZulu-Natal and Port Elizabeth), 
funded by Pharma Dynamics and the Willowton group and 
partnered with Mediclinic for free health screenings as well. 
We had strong media presence with appearances on 
Morning Live on SABC, e-tv  news, the Dr Mol show and 
7de Laan, national and regional radio interviews, print 
media (magazines and newspapers) and a health screening 
challenge between the Gareth Cliff and DJ Fresh teams on 
5FM. The response from the South African public is huge 
as witnessed by a host of phone calls and email enquiries 
as well as a marked leap in website and social media hits.
Cooking from the heart
The HSF was proud to launch a brand new recipe book 
Cooking from the heart in September. The R4 million 
groundbreaking project ran over 2 years. Pharma 
Dynamics’s sole sponsorship ensures the book is made 
freely available to the public.
The recipes in the book recognise the need for tasty, 
healthier versions of family favourites, using affordable 
ingredients commonly found in SA kitchens. “Tasty”  was a 
prerequisite to dispel the myth that healthy food is 
inevitably bland. To our knowledge, there is no equivalent 
resource in the country. The Chronic Diseases Initiative in 
Africa and Medical Research Council provided the research 
to ensure the recipe book was evidence-based to ensure it 
is relevant and appropriate.
We collected the nation’s favourite recipes from around 
country. These  were adapted and tested by our dieticians 
and food consultant Heleen Meyer, to ensure the recipes 
remain healthy, delicious and easy to make. 
The low carbohydrate, high fat debate
The HSF released a position statement on the recent 
debate initiated by Prof Tim Noakes on protein and fat 
loading. Whilst the argument presented by Prof Noakes 
holds some merits, there are some elements that greatly 
concern us. We also note our support of the arguments 
presented by the cardiologists in their letter to the Cape 
Times dated 14 September.  
The HSF doesn’t deny that some fats in the diet are 
important, but the type of fat is important. The real issue is 
the quality of fats we eat weighted against the total 
kilojoules in the diet. While studies are unclear about the 
effect of saturated fats on health, there is solid proof that 
replacing saturated fats with unsaturated fats will improve 
cholesterol levels, reduce heart disease risk and prevent 
insulin resistance, a precursor of diabetes. Eating good fats 
instead of saturated fats lowers the risk of heart disease.  
We trust that Prof Noakes is not recommending that 
people increase their trans fat intake which significantly 
increases the risk for cardiovascular disease (CVD) and 
should thus be avoided. Trans fats have a worse effect on 
cholesterol levels than saturated fats. They also fire 
inflammation which Prof Noakes quite rightly refers to 
and raise the risk of CVD and diabetes. This type of fat 
is commonly found in re-used frying oil (as found in 
restaurants or fast food outlets), commercially fried and 
baked foods, processed snacks and hard margarines. 
There is no doubt that unrefined or wholegrain carbo-
hydrates are healthy and protective against certain diseases 
including cancer. Refined carbohydrates on the other hand 
should be treated with caution. The real issue is the 
abundance of refined carbohydrates found in many every-
day foods. These, together with hidden sugars and fats, are 
the traps found in most processed and convenience foods.
In reality, when people cut back on fat, they fill up on 
foods full of refined carbohydrates (e.g. white bread, 
sugary drinks) or use fat-free products without the healthy 
fats and which contain hidden sugars. The result is an 
increased risk for obesity, CVD and diabetes, which is 
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why we recommend replacing foods high in bad fats with 
foods high in good fat, not with refined carbohydrates.
Then there is matter of over-simplifying the causes of heart 
disease. It is common knowledge that the causes of heart 
disease are multi-factorial, and are not exclusive to only 
blood cholesterol and a high fat diet as claimed. In fact, 
overweight and obesity are one of the risk factors. 
Maintaining a healthy weight requires much more than a 
diet. It means having to balance your energy intake with 
energy used through exercise. Despite Prof Noakes 
advocating exercise together with his diet, the exercise 
message gets lost in the debate, which is a danger. 
As the Harvard School of Public Health reminds us, "looking 
at a single nutrient in isolation cannot tell us the whole 
story about a person’s heart disease risk. It is important to 
remember that people eat food not nutrients and it is 
eaten in an overall dietary pattern”. To ignore other 
contributing factors, behaviours and living context that 
lead to heart disease would be erroneous and dangerous. 
World Stroke Day: 29 October
29 October was World Stroke Day and the HSF had an 
awareness drive. We will be highlighting the causes of 
stroke.  
Draft salt regulations released for comment
The DOH (Department of Health) released draft regula-
tions on 11 July 2012, proposing maximum limits for the 
sodium content of a range of widely consumed foods. The 
HSF commends the Minister of Health for taking this bold 
step, and fully supports the proposed legislation as it will 
play a significant role in decreasing population salt intake 
and the burden of hypertension and CVD in South Africa. 
The proposed regulation aims to gradually reduce the 
sodium content of certain commonly consumed foods, 
with an initial reduction by June 2016 and a further 
reduction by June 2018. This gradual reduction in salt 
content will allow for taste adaptation by the public, and 
give time for food producers to reformulate their products. 
In a bid to support the proposed legislative changes, the 
HSF is joining forces with all interested  stakeholders to 
drive a public awareness campaign which will educate 
consumers on the effects of salt on health and encourage 
behaviour modification. The HSF encourages all organi-
sations and health practitioners to support the proposed 
regulation. 
Draft regulations on smoking in public and 
certain outdoor public places
New regulations have been proposed to ensure that all 
public places and certain outdoor public places in South 
Africa will become 100% smoke-free. Given the great 
harms resulting from tobacco use, the HSF is delighted and 
hopes that the proposed regulations will go a long way in 
reducing the health risks and deaths attributable to 
exposure to second hand smoke (SHS).
Vulnerable groups such as children are being exposed to 
SHS (second hand smoke) mainly by adults in places where 
children live. Some researchers have found that exposure 
to SHS increased a non-smoking pregnant woman's 
chances of stillbirth by 23%, and increased the risk of 
delivering a baby with birth defects by 13%. The risk to 
children also extends beyond the period immediately 
after birth. The Centre for Disease Control (CDC) identi-
fies several health effects of SHS on children, including ear 
infections, more frequent and severe asthma attacks, 
respiratory symptoms, respiratory infections and a greater 
risk for sudden infant death syndrome (SIDS).
There is no safe level of exposure to SHS as much as there 
is no right to smoke in the constitution of the Republic of 
South Africa. In fact, in some countries such as the United 
States of America it has been shown that a smoking ban is 
the only means of effectively eliminating exposure to SHS. 
The HSF strongly supports these draft regulations, and calls 
on health practitioners in all fields to support them too.
For more information, visit www.heartfoundation.co.za.
Dr Vash Mungal-Singh 
Chief Executive Officer
Heart and Stroke Foundation SA (HSF)
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CONGRESS A MINDBOGGLING, WONDERFUL EXPERIENCE
I was very pleased and excited when told that I was one of 
the Fellows to be sponsored by SASCI and Winthrop to 
attend the ESC congress in Munich. It was my first trip to 
such a high profile event. The sheer scale of the whole 
congress was mindboggling with 28 000 delegates attending 
and at least 120 sessions over the 5 days. Nevertheless, it 
was well organised and every session I attended started on 
time without any hitches. 
With a 500 page programme, deciding what to attend was 
always going to be difficult, and I often had to choose 
between 3 or 4 interesting sessions that were being held 
at the same time. I therefore decided to attend sessions 
that would have clinical relevance and would improve my 
knowledge and abilities in the wards:
 ■    I particularly enjoyed a session on cardiogenic shock, 
looking at the pathophysiology, prevention of and new 
modalities of treatment. 
 ■    Eugene Braunwald chaired an excellent session entitled 
“Thrombin and its role in Acute Coronary Syndromes”. 
This was where the Plato study was mentioned and 
the differences between Ticagrelor and Clopidogrel 
were highlighted. 
 ■    The hotline sessions were great and it was fascinating 
how, as soon as a Study was presented, it was 
published immediately in one of the major journals 
online. 
 ■    The inventor of TAVI, Henning Anderson, gave a very 
emotional talk about the early days and how he 
needed to persevere for 23 years before getting 
anywhere. 
 ■    The Bruguda Brothers chaired a brilliant session on the 
diagnosis of Brugada Syndrome and I also learnt a 
great deal about LV assist devices.
 ■    I also attended a few sessions dealing with lipids and 
newer modalities of treatment to control dyslipidaemia. 
All in all, it was a wonderful experience, and I am deeply 
indebted to Professor Sarkin for the nomination, as well as 
the wonderful people from SA Heart and SASCI. 
Parmanand Naran
Steve Biko Academic Hospital, University of Pretoria
Attending the ESC annual conference in Munich as 
part of the Young Cardiologists of Tomorrow pro-
gramme are from left Drs T. Butau, P. Naran, 
(Dr A. Jafta accompanying), N. Gogo and S.D. Mthiyane 
sharing in the fun.
Here are (from left) Drs S.D. Mthiyane, T. Butau and 
P. van der Bijl representing South Africa on the 
Cardiologists of Tomorrow programme supporting 
the SA Heart display at the ESC Congress in Munich. 
The Cardiologists of Tomorrow programme had a 
dedicated lounge for the young cardiologists at the 
recent ESC congress in Munich.
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FEEDBACK: ESC CONGRESS 2012, MUNICH 25 - 29 AUGUST 2012
Arguably the premier event on the global cardiology 
calendar, the European Society of Cardiologists’ (ESC) 
congress certainly lived up to its reputation. With more 
than 30 000 attendees from all continents, the epithet 
“European” is almost a misnomer. It was an honour and 
a privilege to attend, and I wish to thank SA Heart, 
SASCI and Medtronic (South Africa) for facilitating my 
participation.
Many of the presentations were of a superlative standard, 
and of particular note is the fact that a significant number 
of sessions were either chaired or presented by the authors 
of the ESC guidelines on the relevant topic. 
I gained insight into not only the cutting edge of cardiology 
and “breaking” trials (e.g. IABP-SHOCK-II, putting paid 
to the notion that intra-aortic balloon-counterpulsation 
influences mortality, FAME-II, supporting the use of FFR 
in patients with stable, ischaemic heart disease and 
SERAPHIN, investigating the potential for macitentan, a 
novel endothelin-antagonist, in the treatment of pulmonary 
hypertension) but also rationales for constituting guidelines 
and overviews of the evidence for best practice. Other 
highlights were the concluding session, furnishing a resume 
of all the most salient aspects and the appearance of 
household names in Cardiology, like Alain Cribier and 
Ottavio Alfieri. Recurring themes in parallel sessions 
appeared to be secondary, mitral regurgitation and inter-
ventional treatment thereof, imaging of ischaemic heart 
disease, the treatment of pulmonary hypertension and 
novel approaches to the treatment of cardiac failure.
The Munich congress centre is modern, accessible and the 
organisation generally was seamless. Free internet access 
was provided as well as lunch boxes in neat, fold-away 
containers. Two large exhibition halls were filled to capacity 
with trade representation, even including a flight simulator 
taking the “shrunken-down” cardiologist on a headlong 
voyage through the pulmonary circulation!
The travel and accommodation arrangements made by 
Tourvest Travel Services and my stay in the Victor’s 
Residenz Hotel were superb. The representative from 
Medtronic, South Africa (Claude van der Merwe) was an 
excellent host, and I experienced Munich as a welcoming 
venue.
Dr Pieter van der Bijl
Here readers can get a bird’s eye view of the venue for 
the ESC’s conference in Munich, Germany. 
Claude van der Merwe from Medtronic (left) as host 
for the 5 candidates of the Young Cardiologists of 
Tomorrow, Drs S. Mthiyane, P. van der Bijl, P. Naran, 
N. Gogo and T. Butau enjoying a light moment.
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BILLING AND CODING ISSUES
SA Heart has been busy with various coding issues and 
negotiations with Discovery Health and I gladly report back 
on some vitally important issues which members need to 
be aware of. 
Unsatisfactory audit resolved
First, one of our cardiologists was audited by Discovery 
Health in view of charging ICU rates when patients were 
actually treated in a High Care Unit (HCU). This led to a 
disparity in the level of care charged by the hospital and 
the treating cardiologist. The result unfortunately was a 
reversal of just over R188 000 in fees received! 
The audit had led to an extremely acrimonious situation 
and both the cardiologist and Discovery requested SA 
Heart to intervene. It had been explained that our 
colleague’s hospital has a small ICU which is often full 
and, as a result, patients requiring active haemodynamic 
and cardiovascular intervention are therefore sometimes 
treated in the HCU. Category 2 or 3 ICU rates were 
however charged. 
Two of us from SA Heart examined the case records of a 
representative sample and came to the conclusion that an 
ICU charge was appropriate for the clinical setting of each 
patient. They were all ill, warranting active intervention and 
not merely monitoring (which is what a HCU is for). 
Discovery had also stated that these patients were hardly 
ever downgraded and discharged from a general ward. The 
Discovery data however showed the vast majority of 
patients did in fact go to a general ward before discharge. 
A report of our conclusions was issued to Discovery and 
the funds were reimbursed back to the cardiologist in full. 
 ■    We recommended that a future solution for this 
hospital would be to extend its ICU to accommodate 
such ill patients. 
 ■    In addition our colleague will now liaise better with the 
case manager to inform Discovery if an ICU patient 
has to be treated in the HCU because of a lack of 
beds. 
 ■    We ask you all to be cautious w.r.t. ICU/HCU coding 
so that this situation does not arise again. The funders 
are profiling everyone to assess outliers and disparities. 
 ■    Please note: The code 1204 for high care can only be 
charged by the primary doctor. The other specialists 
assisting with clinical management may only charge 
ward rates for their services. 
 ■    Discovery has now also agreed that it will approach 
SA Heart about individual cardiologist billing prob-
lems. The company will not individually audit and 
investigate our members without approaching SA 
Heart first.
Problems with coding
We have been approached about other coding problems 
and SA Heart has decided the following with regard to 
other coding issues raised by Discovery: 
 ■    That it is unreasonable to charge code 1230 for ECG 
interpretation when one has performed either a 
resting (code 1232) or effort ECG (code 1235). 
 ■    Allocating the same theatre time for the insertion of a 
temporary pacemaker as for a permanent pacemaker 
should be left entirely to the discretion of the attending 
cardiologist. You may therefore be asked for a 
motivation in this regard. 
Please note: SA Heart would like to distance us from the 
SAMA opinion that was obtained from an individual 
cardiologist about this particular coding and pacing issue. 
We do not agree with this statement. We ask SA Heart 
members not to give individual opinions to the funders 
which may be problematic in the future. These should be 
released by consensus through SA Heart or the appropriate 
SIG (special interest group). 
Stents
 ■    Discovery has decided to impose the CPT rule that 
one may not charge for more than one stent in the 
same vessel or its side-branch. It has however, been 
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repudiating virtually all claims for multiple stents even 
though these might have been deployed in different 
vessels. The company further stated that it cannot 
recognise where these have been deployed. The latter 
has led to more motivations and an unnecessary 
administrative burden. 
Please note: We ask you all to investigate whether your 
practice accounting software can accommodate the actual 
description of which vessel was treated. i.e. 1286 or 1287 
and stating in brackets RCA, Circumflex, LAD, so that 
Discovery will know what vessels were treated. Discovery 
has stated that it will then remunerate and not repudiate 
the claim, if it is able to identify that different vessels were 
addressed.
PCI and stenting
We have stated to Discovery that this still poses a major 
problem for us. PCI (Percutaneous Cardiac Intervention) 
and stenting requires much skill, training and responsibility. 
The procedure may be extremely complex and often more 
than one stent is required to fully revascularise the patient 
optimally. 
 ■    Discovery has stated that if the stent procedure was 
complex, the cardiologist(s) may apply to be more 
fully remunerated on rule J. This however does not 
guarantee payment, but will be considered. We have 
asked whom we as the cardiology community can 
easily liaise with i.e. a direct email or fax number of 
an individual medical officer who is knowledgeable 
regarding these procedures. We are presently awaiting 
a directive from Discovery in this regard.
 ■    We plan to meet again with Discovery particularly on 
the stenting issue and will include SASCI in on these 
discussions. 
 ■    We also most importantly plan to take the stent 
problems/rule back to the next SAMA coding com-
mittee to have the rule changed once and for all. 
Rule G
Discovery last year also tried to impose Rule G (i.e. a 
global fee that encompasses follow-up for either 30, 60 or 
90 days) on electrophysiology percutaneous procedures. 
The company agreed that it was wrong in this regard. The 
global fee clearly does not apply to any such medical 
procedures apart from permanent pacing which is clearly 
stated in the CPT manual. We also will take this to the 
SAMA coding committee to increase the rand value for 
pacing. The current fees paid for pacing are not fair/
commensurate with the skill, responsibility and time taken 
for pacemaker insertion. 
Apology
We have clearly stated to Discovery that an apology/
retraction is due to the electrophysiologists who were 
audited last year. This had created much anxiety and anger. 
To the best of our knowledge an individual retraction has 
never been issued. We would like to hear from you if you 
were subject to one of these audits. 
We hope to continue our constructive engagement with 
Discovery in the future. We are also going to assist the 
company in revamping its drug formulary. We hope that 
this will lead to positive changes. 
Lastly, please forward us any problems with the funders 
that you are having. We would like to deal head on with 
these issues to make constructive changes. 
David Jankelow 
Secretary, SA Heart
PCI and stenting 
requires much skill, 
training and 
responsibility. 
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TOOLBOX FOR PREVENTION OF CARDIOVASCULAR DISEASE UPDATED
Cardiovascular disease remains the most important cause 
of premature death in developed countries but the pre-
valence in developing countries is increasing dramatically. 
More than 80% of CVD mortality worldwide occurs in 
developing countries, South Africa being no exception. 
Recognising and managing cardiovascular risk is the only 
effective way to have a positive impact on this growing 
epidemic. 
The latest ESC guidelines for the prevention of CVD(1) 
were launched in May 2012 at the annual meeting of 
the European Association for Cardiovascular Prevention & 
Rehabilitation (EACPR), EuroPRevent 2012, in Dublin, 
Ireland, and published simultaneously in the European 
Heart Journal and the European Journal of Preventive 
Cardiology. This guideline document is an important 
resource to guide us to effectively manage our patients 
at risk. 
The guidelines were prepared by the 5th Joint Task Force 
(JTF) on Cardiovascular Disease Prevention which was 
composed of representatives of the ESC and 8 other 
societies including the European Atherosclerosis Society, 
European Society of Hypertension and European Associa-
tion for Study of Diabetes. 
The 2012 guidelines update the previous ESC guidelines 
issued in 2007(2) in a number of ways, including reduced 
length, greater emphasis on current scientific knowledge 
and the use of both traditional and contemporary grading 
systems to adapt more evidence-based recommendations 
for the needs of clinical practice. The update reflects the 
consensus of the participating organisations on the broader 
aspects of CVD prevention based on a comprehensive 
review and critical evaluation of diagnostic and therapeutic 
procedures, including assessment of risk-benefit ratios. For 
more detailed guidance, readers are referred to the specific 
guidelines from the participating societies.
The preparation and publication of the 5th JTF report was 
financially supported by the ESC without any involvement 
of the pharmaceutical industry. The joint task force writing 
this guideline realised that the document was ever-
increasing in size with each new version. They used a dif-
ferent format or formula and, although it is still a very 
comprehensive document, the amount of text compared 
to the previous guidelines was actually reduced. Says 
chairman of the task force, Prof Joep Perk: “This is a 
document in which we try to provide people in clinical 
practice with the rationale and toolbox for the practice of 
CVD prevention.”
What is new or different in these new 
guidelines?
 ■    Both the American College of Cardiology/American 
Heart Association/ESC grading system - which awards 
recommendations for different classes (I, IIa, IIb, or III) 
according to the type of trial evidence - and the British 
Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) system - which allows 
more evidence-based recommendations to be adapted 
to the needs of clinical practice – are used. Prof Perk 
explains: “That was important for us because in 
prevention you have only large population studies. 
You can’t do randomised controlled trials, for example 
assigning smoking to a couple of thousand people and 
not smoking to another couple of thousand, and then 
following them for 20 years. As a result we've had a 
problem with the scientific weight of population 
studies. GRADE takes these figures into account. It 
makes recommendations even easier, especially for 
general practice, because it gives only a strong or a 
weak recommendation. “Strong” means “Do it.” and 
“weak” means “You could do it, but you might well 
wish to put your effort or your money somewhere 
else.” With this approach, we tried to make the 
recommendations as understandable and as easy as 
possible.
 ■    The new guidelines use 4 different levels of cardio-
vascular risk: very high, high, moderate and low. This is 
compatible with the risk groups in the South African 
lipid guidelines, but note that the ESC use the SCORE 
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risk model instead of the Framingham model used in 
the South African lipid guidelines. To avoid confusion 
it is probably best to use the Framingham risk score as 
the preferred model in South Africa.
 ■    The sections of the guidelines on smoking, diet and 
physical exercise, blood pressure, diabetes and lipids 
have been updated. For more detailed information the 
reader is referred to the specific guidelines for lipids, 
diabetes and hypertension. The term “Metabolic 
Syndrome” is not used in these guidelines on the 
advice of diabetologists who do not regard this as a 
disease entity anymore. The focus is rather on the 
different risk factors which constitutes the syndrome. 
 ■    In diabetics the usual treatment target for HbA1c has 
been increased from <6.5% to <7.0%. In the current 
guidelines aspirin is no longer recommended for 
primary prevention in patients with diabetes or non-
diabetics due to its increased risk of bleeding. In the 
acute phase of coronary artery syndromes (CAS) and 
for the following 12 months, dual antiplatelet therapy 
with a P2Y12 inhibitor (ticagrelor or prasugrel) added 
to aspirin is recommended unless contraindicated due 
to excessive risk of bleeding. Clopidogrel is recom-
mended for patients who cannot receive ticagrelor or 
prasugrel. Ticagrelor and prasugrel (in combination 
with aspirin) were proven to be superior to clopidogrel 
plus aspirin in patients with ACS for whom an early 
invasive strategy is planned (Ref: 501-503 in guidelines 
document). In South Africa however, cost effective 
resource allocation may favour the use of generic 
clopidogrel for many of these patients.
 ■    The treatment of periodontitis is another new recom-
mendation. The condition is associated with endothelial 
dysfunction, atherosclerosis, and an increased risk of 
myocardial infarction and stroke and is a risk indicator 
for a generally decreased cardio-vascular health status.
 ■    An element of these guidelines that is completely new 
is the last chapter on where to deliver CVD preven-
tion. The aim is to target a much wider group than 
cardiologists and specialist physicians and to involve 
general practitioners, nurses, the patient and non-
governmental organisations to create and maintain a 
general awareness of the importance of CVD 
prevention. The critical role of the general practitioner 
as the key person to initiate, co-ordinate and to 
provide long-term follow-up for CVD prevention is 
emphasised.
 ■    This comprehensive guidelines document is to be used 
as a reference. 
 ■    At the beginning of each section the key messages are 
listed and at the end the most important new 
information as well as remaining gaps in evidence. The 
reader may find this useful as a summary. 
 ■    The task force will soon publish the pocket guidelines 
which will be much more practical for use in daily 
clinical practice. 
 ■    At this year’s ESC congress in Munich a short one page 
summary will also be made available, especially for 
general practitioners.
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TRAVEL SCHOLARSHIPS OF THE 
SOUTH AFRICAN HEART ASSOCIATION
A maximum of four scholarships will be awarded annually. 
Grants for international meetings will be a maximum of R20 000 
and local meetings a maximum of R7 500.
The travel scholarship is available to all members and associate members living in South Africa and primarily aims to 
assist junior colleagues. In doing so, continued future participation in local or international scientific meetings/workshops 
is encouraged.
REQUIREMENTS
■ Applicants must be fully paid-up members/associate members in good standing for at least one year.
■ Applications need to include:
 ■ Full details of the meeting/workshop;
 ■ The applicant’s abbreviated CV; and
 ■ A breakdown of the anticipated expenses.
■ Applications must reach the Association a minimum of 3 months before the event.
RECOMMENDATIONS
■  Acceptance of an abstract submitted by the applicant at the scientific meeting/workshop. (Should acceptance be 
pending, the application need still be submitted 3 months prior with a note stating expected time of approval.) In 
such a case the scholarship might be granted conditionally: that proof of the abstract being accepted is submitted 
afterwards);
■ An invitation to participate as an invited speaker at the meeting;
■ Publications in a peer reviewed journal/s in the preceding year;
■ An applicant from a member of a previously disadvantaged community; and
■ An application from a member younger than 35 years of age.
ADDRESS APPLICATIONS TO:
The President
South African Heart Association
PO Box 19062
Tygerberg
7505
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international meeting. Should such an abstract not be 
accepted by the relevant congress organising committee, 
the applicant will forfeit his or her sponsorship towards 
the congress. (Application can however be made well in 
advance of the relevant congress but will only be awarded 
on acceptance of the abstract.) A written report on the 
relevant congress attended will need to be submitted by 
the successful applicant within 6 weeks of attending the 
congress. The congress report will be published in the 
South African Heart Association Newsletter.
Applications should be sent to Prof Johan Brink, President 
of the Cape Western branch of the South African Heart 
Association, Chris Barnard Division of Cardiothoracic 
Surgery, Cape Heart Centre, Faculty of Health Sciences, 
University of Cape Town, Anzio Road, Observatory, 7925 
or alternatively email: johan.brink@uct.ac.za.
Previous recipients with this prestigious award were 
Sandrine Lecour, Roisin Kelle and Liesl Zühlke.     
Applications close on 31 January 2013.
LOUIS VOGELPOEL TRAVELLING SCHOLARSHIP
A gifted and 
enthusiastic 
teacher he was 
instrumental in 
the training of 
generations of 
undergraduates.
A pplications are invited for the annual Louis Vogelpoel Travelling Scholarship for 2013. An amount of up to R15 000 towards the travel and 
accommodation costs of a local or international congress 
will be offered annually by the Cape Western branch of the 
South African Heart Association in memory of one of South 
Africa’s outstanding cardiologists, Dr Louis Vogelpoel.  
Louis Vogelpoel was a pioneer of cardiology in South 
Africa who died in April 2005. He was one of the founding 
members of the Cardiac Clinic at Groote Schuur Hospital 
and University of Cape Town. He had an exceptional career 
over more than 5 decades as a distinguished general physi-
cian, cardiologist and horticultural scientist. Dr Vogelpoel’s 
commitment to patient care, teaching and personal edu-
cation is remembered by his many students, colleagues and 
patients. Medical students, house officers, registrars and 
consultants benefited from exposure to his unique blend 
of clinical expertise, extensive knowledge, enthusiasm and 
gracious style. 
A gifted and enthusiastic teacher he was instrumental in 
the training of generations of under-graduates by regular 
bedside tutorials. He served as an outstanding role model 
for post-graduates and many who have achieved pro-
minence nationally and internationally acknowledged his 
contribution to the development of their careers. 
All applications for the scholarship will be reviewed by the 
executive committee of the Cape Western branch of the 
South African Heart Association. Preference will be given 
to practitioners or researchers in the field of cardiovascular 
medicine who are members of the South African Heart 
Association and are resident in the Western Cape.
Applications should include (1) A brief synopsis of the 
work the applicant wishes to present at the congress and 
(2) A brief letter of what the applicant hopes to gain by 
attending the relevant congress. The applicant should sub-
mit an abstract for presentation at the relevant national or 
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TRIBUTE TO PROF ANDRIES JACOB BRINK  29 AUGUST 1923 - 17 OCTOBER 2012
It is with great regret that 
we announce the death of 
Prof Andries Brink, former 
Dean of the Medical Faculty 
and Head of Cardiology at 
Tygerberg Hospital, Univer-
sity of Stellenbosch and 
previously the President of 
the South African Medical 
Research Council.
Prof Brink was among the modern pioneers who brought 
South African cardiology to the attention of the worldwide 
medical community. He achieved this through his own 
original research and later in his career by creating oppor-
tunities for others to conduct research which enhanced 
patient care throughout our continent.
In South Africa, he was a founder of the Faculty of Medicine, 
University of Stellenbosch; first President of the South 
African Medical Research Council (SAMRC) and a driving 
force in establishing the South African Heart Foundation. 
He contributed further to the development and subsequent 
success of more than 25 organisations including the South 
African Medical and Dental Council, the South African 
Council for Scientific Research (CSIR), the Prime Minister’s 
Scientific Advisory Council and the Council of the 
University of Stellenbosch.
Prof Brink’s many achievements were recognised by aca-
demic institutions, professional organisations and societies. 
These honours included an Honorary Doctorate from 
the University of Stellenbosch, the Havenga Prize from 
the Suid Afrikaanse Akademie vir Wetenskap en Kuns, the 
Claude Leon Harris Merit Award, the SA Decoration for 
Meritorious Service and the Wellcome Trust Gold Medal.
Throughout his career, Prof Brink was a prolific author of 
many widely cited scientific papers. Additionally, he was 
a passionate believer in the academic development of 
Afrikaans as a modern medical language. After more than 
two decades of intense work, this resulted in the publica-
tion with co-workers of the authoritative Woordeboek 
van Afrikaanse Geneeskundeterme, which at last provided 
healthcare professionals and patients with the medical 
terminology which is now commonly used throughout 
South Africa.
More recently Prof Brink dedicated himself to bringing 
cardiology in Africa to a global audience. As always he led 
from the front. In 1990, he founded the Cardiovascular 
Journal of South Africa which he was determined should be 
“world class”. As a result of the standards he set, the 
Journal achieved full Medline recognition within 10 years. 
Then, as South Africa became a member of the African 
cardiology community, Prof Brink with the support of 
the Pan African Society for Cardiology opened this Journal 
to the Continent, creating another unique contribution to 
the development of medical education in Africa.
Benewens Prof. Brink se talle veelbekroonde akademiese 
prestasies, is sy lewe besonders gedenkwaardig weens sy 
positiewe bydraes in ander se lewens, nie net op grond van 
wat hy vermag het nie, maar selfs belangriker, deur sy 
menswees. Deur die skep van akademiese platforms vir 
beide onderrig (in die Fakulteit vir Gesondheidsorg aan die 
Universiteit van Stellenbosch) en navorsing (in die Mole-
kulêre en Sellulêre Navorsingseenheid in die Departement 
van Kardiologie aan die Universiteit van Stellenbosch, die 
Suid-Afrikaanse Mediese Navorsingsraad en die Suid-
Arikaanse Hartstigting) het hy bygedra tot die skep van 
wêreldwyd-erkende uitnemendheid in medisyne in Suid 
Afrika.  Prof. Brink het toewyding as die sleutelelement vir 
hoë kwaliteit navorsingsuitsette beskou; dit het mede-
werkers en navorsers besiel om hulself uit te daag en 
sodoende professioneel en akademies te groei (al was die 
proses soms bra ongemaklik!).  Eienskappe wat kenmerkend 
was van Prof. Brink was sy fyn oplettendheid, vernuftige 
speursin, ondubbelsinnige uitsprake, waardering vir die 
kunste en die kuns óm te lewe, sy liefde vir sy mense, vir 
grond en natuur – en natuurlik ook sy skerp sin vir humor 
wat herkenbaar was aan ’n onverwagse binne-pret lag.   
The editors and editorial staff
Cardiovascular Journal of Africa
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THE SOUTH AFRICAN HEART ASSOCIATION
RESEARCH SCHOLARSHIP
The research scholarship is available to all full and associate members of SA Heart Association living in South Africa. It 
is primarily intended to assist colleagues involved in much-needed research to enhance their research programmes.
REQUIREMENTS
■ Applicants need to be fully paid-up members/associate members in good standing for at least one year.
■ Applications must include
 ■ The applicant’s abbreviated CV;
 ■ A breakdown of the anticipated expenses; and
 ■ Full details of the research.
RECOMMENDATIONS
Publications of related work in a peer reviewed journal in the preceding year;
Applicants from a previously disadvantaged community; and
Applicants younger than 35 years of age.
ADDRESS APPLICATIONS TO:
Education Standing Committee
South African Heart Association
PO Box 19062
Tygerberg
7505
THE SELECTION PANEL WILL REVIEW APPLICATIONS ANNUALLY ANDTHE CLOSING DATE IS 
SEPTEMBER 30.
One scholarship to a maximum amount of R50 000 will be awarded annually.
APPLICATIONS WILL BE ASSESSED ACCORDING TO THE ACCOMPANYING RESEARCH PROTOCOL 
WHICH SHOULD INCLUDE:
■ An abstract (maximum 200 words);
■ A brief review of the literature (maximum 200 words);
■ A brief description of the hypothesis to be investigated (maximum 100 words);
■ A detailed methodology (maximum 500 words); and
■ References.
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